Genetic and functional changes in mitochondria associated with aging

Physiological Reviews

Volumn 77, Issue 2, 1997, Pages 425-464

  Ozawa, Takayuki ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; DNA FRAGMENT; MITOCHONDRIAL DNA;

AGING; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; ATROPHY; CELL DEATH; DEGENERATIVE DISEASE; DELETION MUTANT; GENE REARRANGEMENT; GENOTYPE; HUNTINGTON CHOREA; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; OXIDATIVE STRESS; POINT MUTATION; POLYMERASE CHAIN REACTION; PREMATURE AGING; PRIORITY JOURNAL; RESPIRATORY CHAIN; TISSUE DEGENERATION;

EID: 0030897739     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.1997.77.2.425     Document Type: Article

References (440)

1. ABE, K., H. FUJIMURA, Y. NISHIKAWA, S. YORIFUJI, T. MEZAKI, N. HIRONO, N. NISHITANI, AND M. KAMEYAMA. Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Acta Neurol. Scand. 83: 356-359, 1991.
2. ADACHI, K., Y. FUJIURA, F. MAYUMI, A. NOZUHARA, Y. SUGIU, T. SALCANASHI, T. HIDAKA, AND H. TOSHIMA. A deletion of mitochondrial DNA in murine doxorubicin-induced cardiomyotoxicity. Biochem. Biophys. Res. Commun. 195: 945-951, 1993.
3. AHNE, A., J. MULLER-DERLICH, A. M. MERLOS-LANGE, F. KANBAY, K. WOLF, AND B. F. LANG. Two distinct mechanisms for deletion in mitochondrial DNA of Schizosaccharomyces pombe mutator strains. Slipped mispairing mediated by direct repeats and erroneous intron splicing. J. Mol. Biol. 202: 725-734, 1988.
4. AIDA, M., AND S. NISHIMURA. An ab initio molecular orbital study on the characteristics of 8-hydroxyguanine. Mutat. Res. 192: 83-89, 1987.
5. ALLEN, R. J., S. DIMAURO, D. L. COULTER, A. PAPADIMITRIOU, AND S. P. ROTHENBERG. Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate. Ann. Neurol. 13: 679-682, 1983.
6. ALTMAN, R. Die Elementarorganismen und Ihre Beziehungen zur den Zellen. Keipzig, Germany: Veit, 1890.
7. ANDERSON, S., A. T. BANKIER, B. G. BARRELL, M. H. L. DE BRUIJN, A. R. COULSON, J. DROUIN, I. C. EPERON, D. P. NIERLICH, B. A. ROE, F. SANGER, P. H. SCHREIER, A. J. H. SMITH, R. STADEN, AND I. G. YOUNG. Sequence and organization of the human mitochondrial genome. Nature Lond. 290: 457-465, 1981.
8. AQUADRO, C. F., AND B. D. GREENBERG. Human mitochondrial DNA variation and evolution: analysis of nucleotide sequences from seven individuals. Genetics 103: 287-312, 1983.
9. ARNAUDO, E., M. DALAKAS, S. SHANSKE, C. T. MORAES, S. DIMAURO, AND E. A. SCHON. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337: 508-510, 1991.
10. ARNHEIM, N., AND G. CORTOPASSI. Deleterious mitochondrial DNA mutations accumulate in aging human tissues. Mutat. Res. 275: 157-167, 1992.
11. ARTS, W. F., H. R. SCHOLTE, J. M. BOGAARD, K. F. KERREBIJN, AND I. E. LUYT-HOUWEN. NADH-CoQ reductase deficient myopathy: successful treatment with riboflavin. Lancet 2: 581-582, 1983.
12. ASHLEY, M. V., P. J. LAIPIS, AND W. W. HAUSWIRTH. Rapid segregation of heteroplasmic bovine mitochondria. Nucleic Acids Res. 17: 7325-7331, 1989.
13. BALLINGER, S. W., J. M. SHOFFNER, S. GEBHART, D. A. KOONTZ, AND D. C. WALLACE. Mitochondrial diabetes revisited. Nature Genet. 7: 458-459, 1994.
14. BALLINGER, S. W., J. M. SHOFFNER, E. V. HEDAYA, I. TROUNCE, M. A. POLAK, D. A. KOONTZ, AND D. C. WALLACE. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nature Genet. 1: 11-15, 1992.
15. BANDY, B., AND A. J. DAVISON. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging? Free Radical Biol. Med. 8: 523-539, 1990.
16. BANK, W., AND B. CHANCE. An oxidative defect in metabolic myopathies: diagnosis by noninvasive tissue oximetry. Ann. Neurol. 36: 830-837, 1994.
17. 2 consumption can explain the simultaneous presence of high longevity and high aerobic metabolic rate in birds. Free Radical Res. 21: 317-327, 1994.
18. BAUMER, A., C. ZHANG, A. W. LINNANE, AND P. NAGLEY. Age-related human mtDNA deletions: a heterogeneous set of deletions arising at a single pair of directly repeated sequences. Am. J. Hum. Genet. 54: 618-630, 1994.
19. BEAL, M. F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31: 119-130, 1992.
20. BEAL, M. F. Neurochemistry and toxin models in Huntington's disease. Curr. Opin. Neurol. 7: 542-547, 1994.
21. BEAL, M. F., E. BROUILLET, B. JENKINS, R. HENSHAW, B. ROSEN, AND B. T. HYMAN. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J. Neurochem. 61: 1147-1150, 1993.
22. BEAL, M. F., E. BROUILLET, B. G. JENKINS, R. J. FERRANTE, N. W. KOWALL, J. M. MILLER, E. STOREY, R. SRIVASTAVA, B. R. ROSEN, AND B. T. HYMAN. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13: 4181-4192, 1993.
23. BEAL, M. F., D. R. HENSHAW, B. G. JENKINS, B. R. ROSEN, AND J. B. SCHULZ. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann. Neurol. 36: 882-888, 1994.
24. BEHBEHANI, A. W., H. GOEBEL, G. OSSE, M. GABRIEL, U. LANGENBECK, J. BERDEN, R. BERGER, AND R. B. SCHUTGENS. Mitochondrial myopathy with lactic acidosis and deficient activity of muscle succinate cytochrome-c-oxidoreductase. Eur. J. Pediatr. 143: 67-71, 1984.
25. BEHL, C., J. B. DAVIS, R. LESLEY, AND D. SCHUBERT. Hydrogen peroxide mediates amyloid b protein toxicity. Cell 77: 817-827, 1994.
26. BELGUISE-VALLADIER, P., AND R. P. P. FUCHS. Strong sequence-dependent polymorphism in adduct-induced DNA structure: analysis of single N-2-acetyl-aminofluorene residues bound within the Nar I mutation hot spot. Biochemistry 30: 10091-10100, 1991.
27. BENDA, C. Weitere Mittelungen über die Mitochondria. Verh. Physiol. Ges. Berlin 376-383, 1898.
28. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzytne Q in mitochondrial myopathies. Neurology 42: 1203-1208, 1992.
29. BERNSEN, P. L., F. J. GABREELS, W. RUITENBEEK, R. C. SENGERS, A. M. STADHOUDERS, AND W. O. RENIER. Successful treatment of pure myopathy, associated with complex I deficiency, with riboflavin and carnitine. Arch. Neurol. 48: 334-338, 1991.
30. BINDOFF, L. A., C. DESNUELLE, M. M. BIRCH, J. F. PELUSSIER, G. SERRATRICE, C. DRAVET, M. BUREAU, N. HOWELL, AND D. M. TURNBULL. Multiple defects of the mitochondrial respiratory chain in a mitochondrial encephalopathy (MERRF): a clinical, biochemical and molecular study. J. Neurol. Sci. 102: 17-24, 1991.
31. BINDOLI, A. Lipid peroxidation in mitochondria. Free Radical Biol. Med. 5: 247-261, 1988.
32. BLEISTEIN, J., AND S. ZIERZ. Partial deficiency of complexes I and IV of the mitochondrial respiratory chain in skeletal muscle of two patients with mitochondrial myopathy. J. Neurol. 236: 218-222, 1989.
33. BLIN, O., C. DESNUELLE, O. RASCOL, M. BORG, H. PEYRO SAINT PAUL, J. P. AZULAY, F. BILLE, D. FIGARELLA, F. COULOM, AND J. F. PELLISSIER. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J. Neurol. Sci. 125: 95-101, 1994.
34. BOSSI, S. R., J. R. SIMPSON, AND O. ISACSON. Age dependence of striatal neuronal death caused by mitochondrial dysfunction. Neuroreport 4: 73-76, 1993.
35. BOULET, L., G. KARPATI, AND E. A. SHOUBRIDGE. Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF). Am. J. Hum. Genet. 51: 1187-1200, 1992.
36. BOVERIS, A., AND B. CHANCE. The mitochondrial generation of hydrogen peroxide: general properties and effect of hyperbaric oxygen. Biochem. J. 134: 707-716, 1973.
37. BOVERIS, A., N. OSHINO, AND B. CHANCE. The cellular production of hydrogen peroxide. Biochem. J. 128: 617-630, 1972.
38. BOWLING, A. C., E. M. MUTISYA, L. C. WALKER, D. L. PRICE, L. C. CORK, AND M. F. BEAL. Age-dependent impairment of mitochondrial function in primate brain. J. Neurochem. 60: 1964-1967, 1993.
39. BRAVI, D., J. J. ANDERSON, F. DAGANI, T. L. DAVIS, R. FERRARI, M. GILLESPIE, AND T. N. CHASE. Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease. Movement Disord. 7: 228-231, 1992.
40. BRESOLIN, N., C. DORIGUZZI, C. PONZETTO, C. ANGELINI, I. MORONI, E. CASTELLI, E. COSSUTTA, A. BINDA, A. GALLANTI, AND S. GABELLINI. Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial. J. Neurol. Sci. 100: 70-78, 1990.
41. 31P-NMR spectroscopy alterations in a migraine patient. J. Neurol. Sci. 104: 182-189, 1991.
42. BROCKINGTON, M., M. G. SWEENEY, S. R. HAMMANS, J. A. MORGAN-HUGHES, AND A. E. HARDING. A tandem duplication in the D-loop of human mitochondrial DNA is associated with deletions in mitochondrial myopathies. Nature Genet. 4: 67-71, 1993.
43. BROOK, J. D., M. E. MCCURRACH, H. G. HARLEY, A. J. BUCKLER, D. CHURCH, H. ABURATANI, K. HUNTER, V. P. STANTON, J.-P. THIRION, T. HUDSON, R. SOHN, B. ZEMEIMAN, R. G. SNELL, S. A. RUNDLE, S. CROW, J. DAVIE, P. SHELBOURNE, J. BUXTON, C. JONES, V. JUVONEN, K. JOHNSON, P. S. HARPER, D. J. SHAW, AND D. E. HOUSMAN. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (ctg) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68: 799-808, 1992.
44. BROUILLET, E., B. G. JENKINS, B. T. HYMAN, R. J. FERRANTE, N. W. KOWALL, R. SRIVASTAVA, D. S. ROY, B. R. ROSEN, AND M. F. BEAL. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60: 356-359, 1993.
45. BROWN, C. B., J. R. RUSSEL, AND J. L. ROWLAND. Antimycin-insensitive respiration in beef heart mitochondria Biochim. Biophys. Acta 110: 640-642, 1965.
46. BROWN, M. D., M. T. LOTT, A. S. VOLJAVEC, A. TORRONI, AND D. C. WALLACE. Mitochondrial DNA cytochrome b mutations associated with Leber's hereditary optic neuropathy and evidence for deleterious interactions between mutations (Abstract). Am. J. Hum. Genet. 49, Suppl.: 973, 1991.
47. BROWN, M. D., A. TORRONI, K. HUOPONEN, Y. S. CHEN, M. T. LOTT, AND D. C. WALLACE. Pathological significance of the mtDNA COX III mutation at nucleotide pair 9438 in Leber hereditary optic neuropathy. Am. J. Hum. Genet. 55: 410-412, 1994.
48. BROWN, M. D., A. TORRONI, J. M. SHOFFNER, AND D. C. WALLACE. Mitochondrial tRNA Thr mutations and lethal infantile mitochondrial myopathy. Am. J. Hum. Genet. 51: 446-447, 1992.
49. BROWN, M. D., A. S. VOLJAVEC, M. T. LOTT, A. TORRONI, C.-C. YANG, AND D. C. WALLACE. Mitochondrial DNA complex I and III mutations associated with Leber's hereditary optic neuropathy. Genetics 130: 163-173, 1992.
50. BROWN, M. D., C.-C. YANG, I. TROUNCE, A. TORRONI, M. T. LOTT, AND D. C. WALLACE. A mitochondrial DNA variant, identified in Leber hereditary optic neuropathy patients, which extends the amino acid sequence of cytochrome c oxidase subunit I. Am. J. Hum. Genet. 5: 378-385, 1992.
51. BROWN, W. M., M. J. GEORGE, AND A. C. WILSON. Rapid evolution of animal mitochondrial DNA. Proc. Natl. Acad. Sci. USA 76: 1967-1971, 1979.
52. BROWN, W. M., E. M. PRAGER, A. WAN, AND A. C. WILSON. Mitochondrial DNA sequences in primates: tempo and mode of evolution. J. Mol. Evol. 18: 225-239, 1982.
53. BYRNE, E., P. C. BLUMBERGS, J. F. HALLPIKE, AND T. M. MUKHERJEE. Clinical features of mitochondrial myopathy. Aust. N. Z. J. Med. 13: 353-358, 1983.
54. BYRNE, E., AND X. DENNETT. Respiratory chain failure in adult muscle fibres: relationship with ageing and possible implications for the neuronal pool. Mutat. Res. 275: 125-131, 1992.
55. BYRNE, E., X. DENNETT, I. TROUNCE, AND J. BURDON. Mitochondrial myoneuropathy with respiratory failure and myoclonic epilepsy. A case report with biochemical studies. J. Neurol. Sci. 71: 273-281, 1985.
56. BYRNE, E., I. TROUNCE, S. MARZUKI, X. DENNETT, S. F. BERKOVIC, S. DAVIS, M. TANAKA, AND T. OZAWA. Functional respiratory chain studies in mitochondrial cytopathies. Support for mitochondrial DNA heteroplasmy in myoclonus epilepsy and ragged red fibers (MERRF) syndrome. Acta Neuropathol. Berlin 81: 318-323, 1991.
57. CANN, R. L., W. M. BROWN, AND A. C. WILSON. Evolution of human mitochondrial DNA: a preliminary report. Prog. Clin. Biol. Res. 103: 157-165, 1982.
58. CANN, R. L., W. M. BROWN, AND A. C. WILSON. Polymorphic sites and the mechanism of evolution in human mitochondrial DNA. Genetics 106: 479-499, 1984.
59. CANN, R. L., M. STONEKING, AND A. C. WILSON. Mitochondrial DNA and human evolution. Nature Lond. 325: 31-36, 1987.
60. CANN, R. L., AND A. C. WILSON. Length mutations in human mitochondrial DNA. Genetics 104: 699-711, 1983.
61. CASALI, C., F. M. SANTORELLI, G. D. AMATI, P. BERNUCCI, L. DEBIASE, AND S. DIMAURO. A novel mtDNA point mutation in maternally inherited cardiomyopathy. Biochem. Biophys. Res. Commun. 213: 588-593, 1995.
62. CERVERA, R., J. BRUIX, A. BAYES, R. BLESA, I. ILLA, J. COLL, AND A. M. GARCIA-PUGES. Chronic intestinal pseudoobstruction and ophthalmoplegia in a patient with mitochondrial myopathy. Gut 29: 544-547, 1988.
63. CHANCE, B., C. SARONIO, AND J. J. S. LEIGH. Functional intermediates in the reaction of membrane bound cytochrome oxidase with oxygen. J. Biol. Chem. 250: 9226-9232, 1975.
64. CHANCE, B., H. SIES, AND A. BOVERIS. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59: 527-605, 1979.
65. CHANDRASEKARAN, K., T. GIORDANO, D. R. BRADY, J. STOLL, L. J. MARTIN, AND S. I. RAPOPORT. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain. Res. Mol. Brain Res. 24: 336-340, 1994.
66. CHANG, D. D., AND D. A. CLAYTON. Priming of human mitochondrial DNA replication occurs at the light-strand promoter. Proc. Natl. Acad. Sci. USA 82: 351-355, 1985.
67. CHOMYN, A., S. T. LAI, R. SHAKELEY, N. BRESOLIN, G. SCARLATO, AND G. ATTARDI. Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers. Am. J. Hum. Genet. 54: 966-974, 1994.
68. CHOMYN, A., A. MARTINUZZI, M. YONEDA, A. DAGA, O. HURKO, D. JHONS, S. T. LAI, I. NONAKA, C. ANGELINI, AND G. ATTARDI. MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcript. Proc. Natl. Acad. Sci. USA 89: 4221-4225, 1992.
69. CHOMYN, A., G. MEOLA, N. BRESOLIN, S. T. LAI, G. SCARLATO, AND G. ATTARDI. In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. Mol. Cell. Biol. 11: 2236-2244, 1991.
70. CIAFALONI, E., E. RICCI, S. SERVIDEI, S. SHANSKE, G. SILVESTRI, G. MANFREDI, E. A. SCHON, AND S. DIMAURO. Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome. Neurology 41: 1663-1664, 1991.
71. CIAFALONI, E., F. M. SANTORELLI, S. SHANSKE, T. DEONNA, E. ROULET, C. JANZER, G. PESCIA, AND S. DIMAURO. Maternally inherited Leigh syndrome. J. Pediatr. 122: 419-422, 1993.
72. CLARK, J. B., D. J. HAYES, J. A. MORGAN-HUGHES, AND E. BYRNE. Mitochondrial myopathies: disorders of the respiratory chain and oxidative phosphorylation. J. Inherited Metab. Dis. 7, Suppl.: S62-S68, 1984.
73. CLAYTON, D. A. Replication of animal mitochondrial DNA. Cell 28: 693-705, 1982.
74. CLAYTON, D. A. Transcription of the mammalian mitochondrial genome. In: Annual Review of Biochemistry, edited by C. C. Richardson, P. D. Boyer, and A. Meister. Palo Alto, CA: Annu. Rev., 1984, p. 573-594.
75. CLAYTON, D. A. Nuclear gene products that function in mitochondrial DNA replication. Philos. Trans. R. Soc. Lond. B Biol. Sci. 317: 473-482, 1987.
76. CLAYTON, D. A., J. N. DODA, AND E. C. FRIEDBERG. The absence of a pyrimidine dimer repair mechanism in mammalian mitochondria. Proc. Natl. Acad. Sci. USA 71: 2777-2781, 1974.
77. CLEETER, M. W., J. M. COOPER, AND A. H. SCHAPIRA. Irreversible inhibition of mitochondrial complex I by 1-methyl-4- phenylpyridinium: evidence for free radical involvement. J. Neurochem. 58: 786-789, 1992.
78. COLLINS, M. A., E. J. NEAFSEY, K. MATSUBARA, R. J. COBUZZI, AND H. ROLLEMA. Indole-N-methylated beta-carbolinium ions as potential brain- bioactivated neurotoxins. Brain Res. 570: 154-160, 1992.
79. COLLINS, S., C. RUDDUCK, S. MARZUKI, X. DENNETT, AND E. BYRNE. Mitochondrial genome distribution in histochemically cytochrome c oxidase-negative muscle fibres in patients with a mixture of deleted and wild type mitochondrial DNA. Biochim Biophys Acta 1097: 309-317, 1991.
80. COLOMBO, A., E. MERELLI, P. SOLA, P. PANZETTI, D. J. R. QUAGLINO, AND C. FORNIERI. Mitochondrial oculoskeletal myopathy: case report. Ital. J. Neurol. Sci. 9: 385-389, 1988.
81. COOPER, J. M., V. M. MANN, D. KRIGE, AND A. H. SCHAPIRA. Human mitochondrial complex I dysfunction. Biochim. Biophys. Acta 1101: 198-203, 1992.
82. COOPER, J. M., V. M. MANN, AND A. H. SCHAPIRA. Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing. J. Neurol. Sci. 113: 91-98, 1992.
83. COQUET, M., F. DEGOUL, A. VITAL, M. MALGAT, J. P. MAZAT, C. LOUVET-GIENDAJ, D. FONTAN, F. TISON, M. DIRY, AND C. MARSAC. Merrf family with 8344 mutation in tRNA (lys). Evidence of a mitochondrial vasculopathy in muscle biopsies. Neuromuscular Disord. 3: 593-597, 1993.
84. COQUET, M., D. FONTAN, C. VITAL, N. TUDESQ, AND R. BARONNET. Muscle and brain biopsy in a case of mitochondrial encephalomyopathy. Demonstration of a mitochondrial vasculopathy. Ann. Pathol 10: 181-186, 1990.
85. CORMIER, V., A. ROTIG, M. TARDIEU, M. COLONNA, J. M. SAUDUBRAY, AND A. MUNNICH. Autosomal dominant deletions of the mitochondrial genome in a case of progressive encephalomyopathy. Am. J. Hum. Genet. 48: 643-648, 1991.
86. CORRAL-DEBRINSKI, M., T. HORTON, M. T. LOTT, J. M. SHOFFNER, M. F. BEAL, AND D. C. WALLACE. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genet. 2: 324-329, 1992.
87. CORRAL-DEBRINSKI, M., J. M. SHOFFNER, M. T. LOTT, AND D. C. WALLACE. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat. Res. 275: 169-180, 1992.
88. CORTOPASSI, G. A., AND N. ARNHEIM. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res. 18: 6927-6933, 1990.
89. CORTOPASSI, G. A., D. SHIBATA, N. W. SOONG, AND N. ARNHEIM. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc. Natl. Acad. Sci. USA 89: 7370-7374, 1992.
90. COYLE, J. T., AND P. PUTTFARCKEN. Oxidative stress, glutamate, and neurodegenerative disorders. Science Wash. DC 262: 689-695, 1993.
91. DAGANI, F., J. J. ANDERSON, AND T. N. CHASE. Mitochondrial function in Parkinson's disease. Ann. Neurol. 32: 226-227, 1992.
92. DALAKAS, M. C., I. ILLA, G. H. PEZESHKPOUR, J. P. LAUKAITIS, B. COHEN, AND J. L. GRIFFIN. Mitochondrial myopathy caused by long-term Zidovudine therapy. N. Engl. J. Med. 322: 1098-1105, 1990.
93. DANKS, R. A., M. DOREVITCH, J. T. CUMMINS, AND E. BYRNE. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS): adolescent onset with severe cerebral edema. Aust. N. Z. J. Med. 18: 69-72, 1988.
94. DAVIES, K. J. Intracellular proteolytic systems may function as secondary antioxidant defenses: an hypothesis. J. Free Radical Biol. Med. 2: 155-173, 1986.
95. DAVIS, G. C., A. C. WILLIAMS, S. P. MARKEY, M. H. EBERT, E. D. CAINE, C. M. REICHERT, AND I. J. KOPIN. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatr. Res. 1: 249-254, 1979.
96. DEGOUL, F., I. NELSON, P. LESTIENNE, D. FRANCOIS, N. ROMERO, D. DUBOC, B. EYMARD, M. FARDEAU, G. PONSOT, AND J. M. PATURNEAU. Deletions of mitochondrial DNA in Kearns-Sayre syndrome and ocular myopathies: genetic, biochemical and morphological studies. J. Neurol. Sci. 101: 168-177, 1991.
97. DE MASSY, B., AND O. FAYET. Multiple origin usage for DNA replication in sdrA(rnh) mutants of Escherichia coli K-12: initiation in the absence of oriC. J. Mol. Biol. 178: 227-236, 1984.
98. DENG, R. Y., AND I. FRIDOVICH. Formation of endonuclease III sensitive sites as a consequence of oxygen radical attack on DNA. Free Radical Biol. Med. 6: 123-129, 1989.
99. DIMAURO, S., A. LOMBES, H. NAKASE, S. MITA, G. M. FABRIZI, H. J. TRITSCHLER, E. BONILLA, A. F. MIRANDA, D. C. DEVIVO, AND E. A. SCHON. Cytochrome c oxidase deficiency. Pediatr. Res. 28: 536-541, 1990.
100. DI MONTE, D. A. Mitochondrial DNA and Parkinson's disease. Neurology 41: 38-42, 1991.
101. DI MONTE, D. A., P. CHAN, AND M. S. SANDY. Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage? Ann. Neurol. 32: S111-S115, 1992.
102. DRIGGERS, W. J., S. P. LEDOUX, AND G. L. WILSON. Repair of oxidative damage within the mitochondrial DNA of RINr 38 cells. J. Biol. Chem. 268: 22042-22045, 1993.
103. DUNBAR, D. R., P. A. MOONIE, R. J. SWINGLER, D. DAVIDSON, R. ROBERTS, AND I. J. HOLT. Maternally transmitted partial direct tandem duplication of mitochondrial DNA associated with diabetes mellitus. Hum. Mol. Genet. 2: 1619-1624, 1993.
104. 3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc. Natl. Acad. Sci. USA 81: 3529-3533, 1984.
105. ENTER, C., J. MÜLLER-HÖCKER, S. ZIERZ, G. KURLEMANN, D. PONGRATZ, C. FÖRSTER, B. OBSERMAIER-KUSSER, AND K.-D. GERBITZ. A specific point mutation in the mitochondrial genome of Caucasians with MELAS. Hum. Genet. 88: 233-236, 1991.
106. EPHRUSSI, B., H. HOTTINGUER, AND A. M. CHIMENES. Action de l'acriflavine sur les levures. I. La mutation "petite colonie." Ann. Inst. Pasteur 76: 351-367, 1949.
107. FEDERICO, A., F. CORNELIO, S. DI-DONATO, E. EDERLI, G. M. FABRIZI, L. MANNESCHI, AND G. C. GUAZZI. Mitochondrial encephalo-neuro-myopathy with myoclonus epilepsy, basal nuclei calcification and hyperlactacidemia. Ital. J. Neurol. Sci. 9: 65-71, 1988.
108. FEE, J. A., AND J. S. VALENTINE. Chemical and physical properties of superoxide. In: Superoxide and Superoxide Dismutase, edited A. M. Michelsonn, J. M. McCord, and I. Fridovich. New York: Academic, 1977, p. 19-60.
109. FISCHEL-GHODSIAN, N., M. C. BOHLMAN, T. R. PREZANT, J. J. GRAHAM, S. D. CEDERBAUM, AND M. J. EDWARDS. Deletion in blood mitochondrial DNA in Kearns-Sayre syndrome. Pediatr. Res. 31: 557-560, 1992
110. FLEMING, J. E., J. MIQUEL, S. F. COTTRELL, L. S. YENGOYAN, AND A. C. ECONOMOS. Is cell aging caused by respiration-dependent injury to the mitochondrial genome? Gerontology 28: 44-53, 1982.
111. FORSTER, C., G. HUBNER, H. J. MULLER, D. PONGRATZ, P. BAIERL, R. SENGER, AND W. RUITENBEEK. Mitochondrial angiopathy in a family with MELAS. Neuropediatrics 23: 165-168, 1992.
112. FRIM, D. M., J. SIMPSON, T. A. UHLER, M. P. SHORT, S. R. BOSSI, X. O. BREAKEFIELD, AND O. ISACSON. Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. J. Neurosci. Res. 35: 452-458, 1993.
113. FRITZ, T., G. LENZ, AND R. SCHORER. Comments on anesthesia procedures in mitochondrial encephalomyopathy. Anesth. Intensivther. Notfallmed. 23: 265-270, 1988.
114. FRITZ, T., K. WESSEL, E. WEIDLE, G. LENZ, AND J. PEIFFER. Anesthesia for eye operations in mitochondrial encephalomyelopathy. Klin. Monatsbl. Augenheilkd. 193: 174-178, 1988.
115. FUKUNAGA, M., AND K. L. YIELDING. Fate during cell growth of yeast mitochondria and nuclear DNA after photolytic attachment of the monoazide analog of ethidium. Biochem. Biophys. Res. Commun. 90: 582-586, 1979.
116. GARTNER, L. P. The fine structural morphology of the midgut of aged Drosophila: a morphometric analysis. Exp. Gerontol. 22: 297-304, 1987.
117. GERBITZ, K. D., K. B. OBERMAIER, P. LESTIENNE, S. ZIERZ, H. J. MULLER, D. PONGRATZ, B. I. PAETZKE, AND T. DEUFEL. Mutations of the mitochondrial DNA: the contribution of DNA techniques to the diagnosis of mitochondrial encephalomyopathies. J. Clin. Chem. Clin. Biochem. 28: 241-250, 1990.
118. GERBITZ, K. D., K. B. OBERMAIER, S. ZIERZ, D. PONGRATZ, H. J. MULLER, AND P. LESTIENNE. Mitochondrial myopathies: divergences of genetic deletions, biochemical defects and the clinical syndromes. J. Neurol. 237: 5-10, 1990.
119. GESTENBLITH, G., J. FREDERIKSEN, F. C. P. YIN, N. J. FORTUIN, E. G. LAKATTA, AND M. L. WEISFELD. Echocardiographic assessment of a normal adult aging population. Circulation 56: 273-278, 1977.
120. GILES, R. E., H. BLANC, H. M. CANN, AND D. C. WALLACE. Maternal inheritance of human mitochondrial DNA. Proc. Natl. Acad. Sci. USA 77: 6715-6719, 1980.
121. GOATE, A., H. M. CHARTIER, M. MULLAN, J. BROWN, F. CRAWFORD, L. FIDANI, L. GIUFFRA, A. HAYNES, N. IRVING, L. JAMES, R. MANT, P. NEWTON, K. ROOKE, P. ROQUES, C. TALBOT, C. PERICAK-VANCE, A. ROSES, R. WILLIAMSON, M. ROSSOR, M. OWEN, AND J. HARDY. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature Lond. 349: 704-706, 1991.
122. 10 in a patient with mitochondrial encephalomyopathy. J. Neurol. 234: 62-63, 1987.
123. GOLDSTEIN, S., AND L. B. KORCZACK. Status of mitochondria in living human fibroblasts during growth and senescence in vitro: use of the laser dye rhodamine 123. J. Cell Biol. 91: 392-398, 1981.
124. GOTO, Y., S. HORAI, T. MATSUOKA, Y. KOGA, K. NIHEI, M. KOBAYASHI, AND I. NONAKA. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology 42: 545-550, 1992.
125. GOTO, Y., Y. KOGA, S. HORAI, AND I. NONAKA. Chronic progressive external ophthalmoplegia: a correlative study of mitochondrial DNA deletions and their phenotypic expression in muscle biopsies. J. Neurol. Sci. 100: 63-69, 1990.
126. GOTO, Y., I. NONAKA, AND S. HORAI. A mutation in the transfer RNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathy. Nature Lond. 348: 651-653, 1990.
127. GRIEBEL, V., I. KRAGELOH-MANN, W. RUITENBEEK, J. M. TRIJBELS, AND W. PAULUS. A mitochondrial myopathy in an infant with lactic acidosis. Dev. Med. Child Neurol. 32: 528-531, 1990.
128. GRIVELL, L. A. Mitochondrial DNA: small, beautiful and essential. Nature Lond. 341: 569-571, 1989.
129. GROSS, N. J., G. S. GETZ, AND M. RABINOWITZ. Apparent turnover of mitochondrial deoxyribonucleic and mitochondrial phospholipids in the tissues of the rat. J. Biol. Chem. 244: 1552-1562, 1969.
130. GYLLENSTEN, U., D. WHARTON, A. JOSEFSSON, AND A. C. WILSON. Paternal inheritance of mitochondrial DNA in mice. Nature Lond. 352: 255-257, 1991.
131. HABER, F., AND J. J. WEISS. The catalytic decomposition of hydrogen peroxide by iron salts. Proc. R. Soc. Lond. Ser. B Biol. Sci. 147: 332-351, 1934.
132. HAMAZAKI, S., S. OKADA, H. KUSAKA, T. FUJII, T. OKUNO, I. KASHU, AND O. MIDORIKAWA. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Report of an autopsy. Acta Pathol. Jpn. 39: 599-606, 1989.
133. HAMMANS, S. R., M. G. SWEENEY, M. BROCKINGTON, J. A. MORGAN-HUGHES, AND A. E. HARDING. Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples. Lancet 337: 1311-1313, 1991.
134. HAMMANS, S. R., M. G. SWEENEY, I. J. HOLT, J. M. COOPER, A TOSCANO, J. B. CLARK, J. A. MORGAN-HUGHES, AND A. E. HARDING. Evidence for intramitochondrial complementation between deleted and normal mitochondrial DNA in some patients with mitochondrial myopathy. J. Neurol. Sci. 107: 87-92, 1992.
135. HAMMANS, S. R., M. G. SWEENEY, D. A. WICKS, J. A. MORGAN-HUGHES, AND A. E. HARDING. A molecular genetic study of focal histochemical defects in mitochondrial encephalomyopathies. Brain 115: 343-365, 1992.
136. HANNA, M. G., I. NELSON, M. G. SWEENEY, J. M. COOPER, P. J. WATKINS, J. A. MORGAN-HUGHES, AND A. E. HARDING. Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus: different phenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation. Am. J. Hum. Genet. 56: 1026-1033, 1995.
137. HARDING, A. E., AND I. J. HOLT. Mitochondrial myopathies. Br. Med. Bull. 45: 760-771, 1989.
138. HARMAN, D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11: 298-300, 1956.
139. HARMAN, D. Free radical theory of aging: consequences of mitochondrial aging. Age 6: 86-94, 1983.
140. HATTORI, K., T. OGAWA, T. KONDO, M. MOCHIZUKI, M. TANAKA, S. SUGIYAMA, T. ITO, T. SATAKE, AND T. OZAWA. Cardiomyopathy with mitochondrial DNA mutations. Am. Heart J. 122: 866-869, 1991.
141. HATTORI, K., M. TANAKA, S. SUGIYAMA, T. OBAYASHI, T. ITO, T. SATAKE, Y. HANAKI, J. ASAI, M. NAGANO, AND T. OZAWA. Age-dependent increase in deleted mitochondrial DNA in the human heart: possible contributing factor to "presbycardia." Am. Heart J. 121: 1735-1742, 1991.
142. HATTORI, N., M. TANAKA, T. OZAWA, AND Y. MIZUNO. Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann. Neurol. 30: 563-571, 1991.
143. HAUSWIRTH, W. W., AND D. A. CLAYTON. Length heterogeneity of a conserved displacement-loop sequence in human mitochondrial DNA. Nucleic Acids Res. 13: 8093-8104, 1985.
144. HAUSWIRTH, W. W., AND P. LAIPIS. Mitochondrial DNA polymorphism in a maternal lineage of Holstein cows. Proc. Natl. Acad. Sci. USA 79: 4686-4690, 1982.
145. HAYAKAWA, M., K. HATTORI, S. SUGIYAMA, AND T. OZAWA. Age-associated oxygen damage and mutations in mitochondrial DNA in human hearts. Biochem. Biophys. Res. Commun. 189: 979-985, 1992.
146. HAYAKAWA, M., K. KATSUMATA, M. YONEDA, M. TANAKA, S. SUGIYAMA, AND T. OZAWA. Mitochondrial DNA minicircles, lacking replication origins, exist in cardiac muscle of a young normal subject. Biochem. Biophys. Res. Commun. 215: 952-960, 1995.
147. HAYAKAWA, M., T. OGAWA, S. SUGIYAMA, AND T. OZAWA. Hydroxyl radical and leukotoxin biosynthesis in neutrophile plasma membrane. Biochem. Biophys. Res. Commun. 161: 1077-1085, 1989.
148. HAYAKAWA, M., T. OGAWA, M. TANAKA, S. SUGIYAMA, AND T. OZAWA. Massive conversion of deoxy-guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidine. Biochem. Biophys. Res. Commun. 176: 87-93, 1991.
149. HAYAKAWA, M., S. SUGIYAMA, K. HATTORI, M. TAKASAWA, AND T. OZAWA. Age-associated damage in mitochondrial DNA in human hearts. Mol. Cell. Biochem. 119: 95-103, 1993.
150. HAYAKAWA, M., K. TORII, S. SUGIYAMA, M. TANAKA, AND T. OZAWA. Age-associated accumulation of 8-hydroxydeoxyguanosine in mitochondrial DNA of human diaphragm. Biochem. Biophys. Res. Commun. 179: 1023-1029, 1991.
151. HAYASHI, J., S. OHTA, A. KIKUCHI, M. TAKEMITSU, Y. GOTO, AND I. NONAKA. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc. Natl. Acad. Sci. USA 88: 10614-10618, 1991.
152. 31P magnetic resonance and biochemical investigation. J. Neurol. Sci. 71: 105-118, 1985.
153. HAYFLICK, L. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37: 614-636, 1965.
154. HESS, J. F., M. A. PARISI, J. L. BENNETT, AND D. A. CLAYTON. Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature Lond. 351: 236-239, 1991.
155. HOCKENBERG, D. M., Z. N. OLTVAI, X.-M. YIN, C. L. MILLIMAN, AND S. J. KORSMEYER. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251, 1993.
156. HOCKENBERY, D., G. NUNEZ, C. MILLIMAN, R. D. SCHREIBER, AND S. J. KORSMEYER. Bc1-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature Lond. 348: 334-336, 1990.
157. HOLT, I. J., A. E. HARDING, AND J. A. MORGAN-HUGHES. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature Lond. 331: 717-719, 1988.
158. HOLT, I. J., A. E. HARDING, AND J. A. MORGAN-HUGHES. Deletions of muscle mitochondrial DNA in mitochondrial myopathies: sequence analysis and possible mechanisms. Nucleic Acids Res. 17: 4465-4469, 1989.
159. HOLT, I. J., D. H. MILLER, AND A. E. HARDING. Genetic heterogeneity and mitochondrial DNA heteroplasmy in Leber's hereditary optic neuropathy. J. Med. Genet. 26: 739-743, 1989.
160. HORAI, S., K. HAYASAKA, R. KONDO, K. TSUGANE, AND N. TAKAHATA. Recent African origin of modern humans revealed by complete sequences of hominoid mitochondrial DNAs. Proc. Natl. Acad. Sci. USA 92: 532-536, 1995.
161. HOWELL, N., L. A. BINDOFF, D. A. MCCULLOUGH, I. KUBACKA, J. POULTON, D. MACKEY, L. TAYLOR, AND D. M. TURNBULL. Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am. J. Hum. Genet. 49: 939-950, 1991.
162. HOYER, S. Senile dementia and Alzheimer's disease. Brain blood flow and metabolism. Prog Neuropsychopharmacol. Biol. Psychiatry 10: 447-478, 1986.
163. HUBNER, G., J. M. GOKEL, D. PONGRATZ, A. JOHANNES, AND J. W. PARK. Fatal mitochondrial cardiomyopathy in Kearns-Sayre syndrome. Virchows Arch. A Pathol. Anat. Histol. 408: 611-621, 1986.
164. HUOPONEN, K., J. VILKKI, P. AULA, E. K. NIKOSKELAINEN, AND M. L. SAVONTAUS. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am. J. Hum. Genet. 48: 1147-1153, 1991.
165. HURKO, O., D. R. JOHNS, S. L. RUTLEDGE, O. C. STINE, P. L. PETERSON, N. R. MILLER, M. E. MARTENS, D. B. DRACHMAN, R. H. BROWN, AND C. P. LEE. Heteroplasmy in chronic external ophthalmoplegia: clinical and molecular observations. Pediatr. Res. 28: 542-548, 1990.
166. ICHIKI, T., M. TANAKA, M. NISHIKIMI, H. SUZUKI, M. KOBAYASHI, Y. WADA, AND T. OZAWA. Deficiency of subunits of complex I and mitochondrial encephalomyopathy. Ann. Neurol. 23: 287-294, 1988.
167. 10 and idebenone. J. Neurol. Sci. 90: 263-271, 1989.
168. IKEBE, S., M. TANAKA, K. OHNO, W. SATO, K. HATTORI, T. KONDO, Y. MIZUNO, AND T. OZAWA. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. Biochem. Biophys. Res. Commun. 170: 1044-1048, 1990.
169. IKEBE, S., M. TANAKA, AND T. OZAWA. Point mutations of mitochondrial genome in Parkinson's disease. Mol. Brain Res. 28: 281-295, 1995.
170. INO, H., M. TANAKA, K. OHNO, K. HATTORI, S. IKEBE, T. OZAWA, T. ICHIKI, M. KOBAYASHI, AND Y. WADA. Mitochondrial leucine tRNA mutation in a mitochondrial encephalomyopathy. Lancet 337: 234-235, 1991.
171. IONASESCU, V. V., M. HART, S. DIMAURO, AND C. T. MORAES. Clinical and morphologic features of a myopathy associated with a point mutation in the mitochondrial tRNAPro gene. Neurology 44: 975-977, 1994.
172. ISHIMARU, H., S. OGAWA, K. FUJI, T. FUKUTA, T. KAMEYAMA, AND T. NABESHIMA. Age-related changes in learning and memory, choline acetyltransferase activity and number of neuronal cells in rats. J. Pharmacobio-Dyn. 14: 321-325, 1991.
173. IWASE, M., K. NAGATA, H. IZAWA, M. YOKOTA, S. KAMIHARA, H. INAGAKI, AND H. SAITO. Age-related changes in left and right ventricular filling velocity profiles and their relationship in normal subjects. Am. Heart J. 126: 419-426, 1993.
174. JENNER, P. Oxidative stress as a cause of Parkinson's disease. Acta Neurol. Scand. Suppl. 136: 6-15, 1991.
175. JENNER, P. What process causes nigral cell death in Parkinson's disease? Neurol. Clin. 10: 387-403, 1992.
176. JENNER, P., A. H. SCHAPIRA, AND C. D. MARSDEN. New insights into the cause of Parkinson's disease. Neurology 42: 2241-2250, 1992.
177. JINNAI, K., H. YAMADA, F. KANDA, Y. MASUI, M. TANAKA, T. OZAWA, AND T. FUJITA. A case of mitochondrial myopathy, encephalopathy and lactic acidosis due to cytochrome c oxidase deficiency with neurogenic muscular changes. Eur. Neurol. 30: 56-60, 1990.
178. JOHNS, D. R., AND D. R. CORNBLATH. Molecular insight into the asymmetric distribution of pathogenetic human mitochondrial DNA deletions. Biochem. Biophys. Res. Commun. 174: 244-250, 1991.
179. JOHNSON, M. A., D. M. TURNBULL, D. J. DICK, AND H. S. SHERRATT. A partial deficiency of cytochrome c oxidase in chronic progressive external ophthalmoplegia. J. Neurol. Sci. 60: 31-53, 1983.
180. KADENBACH, B., P. SEIBEL, M. A. JOHNSON, AND D. TURNBULL. Mutations of mitochondrial DNA: the molecular basis of mitochondrial encephalomyopathies and ageing? In: Molecular Basis of Neurological Disorders and Their Treatment, edited by J. W. Gorrod, O. Albano, E. Ferrari, and S. Papa. New York: Chapman & Hall, 1991, p. 200-208.
181. KALINOWSKI, D. P., S. ILLENYE, AND B. VAN HOUTEN. Analysis of DNA damage and repair in murine leukemia L1210 cells using a quantitative polymerase chain reaction assay. Nucleic Acids Res. 20: 3485-3494, 1992.
182. KAMIENIECKA, Z., AND H. SCHMALBRUCH. Myopathies with abnormal mitochondria: a clinicopathologic classification. Muscle Nerve 1: 413-415, 1978.
183. KAMIMURA, N., S. ISHII, L. D. MA, AND J. W. SHAY. Three separate mitochondrial DNA sequences are contiguous in human genomic DNA. J. Mol. Biol. 210: 703-707, 1989.
184. KAMIYA, H., K. MIURA, H. ISHIKAWA, H. INOUE, S. NISHIMURA, AND E. OHTSUKA. c-Ha-ras containing 8-hydroxyguanine at codon 12 induces point mutations at the modified and adjacent positions. Cancer Res. 52: 3483-3485, 1992.
185. KATAYAMA, M., M. TANAKA, H. YAMAMOTO, T. OHBAYASHI, Y. NIMURA, AND T. OZAWA. Deleted mitochondrial DNA in the skeletal muscle of aged individuals. Biochem. Int. 25: 47-56, 1991.
186. KATSUMATA, K., M. HAYAKAWA, M. TANAKA, S. SUGIYAMA, AND T. OZAWA. Fragmentation of human heart mitochondrial DNA associated with premature aging. Biochem. Biophys. Res. Commun. 202: 102-110, 1994.
187. KAWAKAMI, Y., R. SAKUTA, K. HASHIMOTO, O. FUJINO, T. FUJITA, M. HIDA, S. HORAI, Y. GOTO, AND I. NONAKA. Mitochondrial myopathy with progressive decrease in mitochondrial tRNA(Leu) (UUR) mutant genomes. Ann. Neurol. 35: 370-373, 1994.
188. KEILIN, D. On cytochrome, a respiratory pigment, common to animals, yeast, and higher plants. Proc. R. Soc. Lond. 98: 312-339, 1925.
189. KENNAWAY, N. G., N. R. BUIST, V. M. DARLEY-USMAR, A. PAPADIMITRIOU, S. DIMAURO, R. I. KELLEY, R. A. CAPALDI, N. K. BLANK, AND A. D'AGOSTINO. Lactic acidosis and mitochondrial myopathy associated with deficiency of several components of complex III of the respiratory chain. Pediatr. Res. 18: 991-999, 1984.
190. KOBAYASHI, M., H. MORISHITA, K. OKAJIMA, N. SUGIYAMA, AND Y. WADA. Successful treatment with succinate supplement in a patient with a deficiency of complex I (NADH: CoQ reductase) (Abstract). Proc. Int. Cong. Inborn Errors Metab. 4th Sendai Japan 1987, p. 148.
191. KOBAYASHI, M., Y. SHIMOMURA, H. SUZUKI, M. TANAKA, H. BAUM, AND T. OZAWA. Structural effects of ubiquinones on the mitochondrial inner membrane. J. Appl. Biochem. 2: 270-279, 1980.
192. KOBAYASHI, Y., M. Y. MOMOI, K. TOMINAGA, H. SHIMOIZUMI, K. NIHEI, M. YANAGISAWA, Y. KAGAWA, AND S. OHTA. Respiration-deficient cells are caused by a single point mutation in the mitochondrial tRNA-Leu (UUR) gene in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Am. J. Hum. Genet. 49: 590-599, 1991.
193. KOBAYASHI, Y., M. Y. MOMOI, K. YOMINAGA, T. MOMOI, K. NIHEI, M. YANAGISAWA, Y. KAGAWA, AND S. OHTA. A point mutation in the mitochondrial tRNALeu(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem. Biophys. Res. Commun. 173: 816-822, 1990.
194. KOEHLER, C. M., G. L. LINDBERG, D. R. BROWN, D. F. BEITZ, J. E. MAYFIELD, AND A. M. MYERS. Replacement of bovine mitochondrial DNA by a sequence variant within one generation. Genetics 129: 247-255, 1991.
195. KOIKE, K., AND D. R. WOLSTENHOLME. Evidence for discontinuous replication of circular mitochondrial DNA molecules from Novikoff rat ascites hepatoma cells. J. Cell Biol. 61: 14-25, 1974.
196. KORNBERG, A., AND T. A. BAKER. DNA Replication. New York: Freeman, 1980.
197. KORSMEYER, S. J., X.-M. YIN, Z. N. OLTVAI, D. J. VEIS-NOVACK, AND G. P. LINETTE. Reactive oxygen species and the regulation of cell death by the Bc1-2 gene family. Biochim. Biophys. Acta 1271: 63-66, 1995.
198. KRIGE, D., M. T. CARROLL, J. M. COOPER, C. D. MARSDEN, AND A. H. SCHAPIRA. Platelet mitochondrial function in Parkinson's disease. Ann. Neurol. 32: 782-788, 1992.
199. KRISTENSEN, T., AND H. PRYDZ. The presence of intact mitochondrial DNA in HeLa cell nuclei. Nucleic Acids Res. 14: 2597-2609, 1986.
200. KRUEGER, M. J., A. K. TAN, B. A. ACKRELL, AND T. P. SINGER. Is complex II involved in the inhibition of mitochondrial respiration by N-methyl-4-phenylpyridinium cation (MMP+) and N-methyl-beta-carbolines? Biochem. J. 291: 673-676, 1993.
201. KUCHLE, M., P. M. BRENNER, A. ENGELHARDT, AND G. O. NAUMANN. Ocular changes in MELAS syndrome. Klin. Monatsbl. Augenheilkd. 197: 258-264, 1990.
202. KURIYAMA, M., M. SUEHARA, N. MARUME, M. OSAME, AND A. IGATA. High CSF lactate and pyruvate content in Kearns-Sayre syndrome. Neurology 34: 253-255, 1984.
203. KURIYAMA, M., H. UMEZAKI, Y. FUKUDA, M. OSAME, K. KOIKE, J. TATEISHI, AND A. IGATA. Mitochondrial encephalomyopathy with lactate-pyruvate elevation and brain infarctions. Neurology 34: 72-77, 1984.
204. KUZUYA, T., S. HOSHIDA, Y. KIM, M. NISHIDA, H. FUJI, A. KITABATAKE, M. TADA, AND T. KAMADA. Detection of oxygen-derived free radical generation in the canine postischemic heart during late phase of reperfusion. Circ. Res. 66: 1160-1165, 1990.
205. LANGSTON, J. W., P. BALLARD, J. W. TERUD, AND I. IRWIN. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science Wash. DC 219: 979-980, 1983.
206. LARSSON, N. G., E. HOLME, B. KRISTIANSSON, A. OLDFORS, AND M. TULINIUS. Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr. Res. 28: 131-136, 1990.
207. LARSSON, N. G., M. H. TULINIUS, E. HOLME, A. OLDFORS, O. ANDERSEN, J. WAHLSTROM, AND J. AASLY. Segregation and manifestations of the mtDNA tRNA(Lys) A→G(8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. Am. J. Hum. Genet. 51: 1201-1212, 1992.
208. LAUBER, J., C. MARSAC, B. KADENBACH, AND P. SEIBEL. Mutations in mitochondrial tRNA genes: a frequent cause of neuromuscular diseases. Nucleic Acids Res. 19: 1393-1397, 1991.
209. LEDOUX, S. P., G. L. WILSON, E. J. BEECHAM, T. STEVNSNER, K. WASSERMANN, AND V. A. BOHR. Repair of mitochondrial DNA after various types of DNA damage in Chinese hamster ovary cells. Carcinogenesis 13: 1967-1973, 1992.
210. LEE, C. M., S. S. CHUNG, J. M. KACZKOWSKI, R. WEINDRUCH, AND J. M. AIKEN. Multiple mitochondrial DNA deletions associated with age in skeletal muscle of rhesus monkeys. Biol. Sci. 48: B201-B205, 1993.
211. LENAZ, G., AND M. D. ESPOSTI. Physical properties of ubiquinones in model systems and membranes. In: Coenzyme Q, edited by G. Lenaz. New York: Wiley, 1985, p. 53-105.
212. LESTIENNE, P., J. NELSON, P. RIEDERER, K. JELLINGER, AND H. REICHMANN. Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defect. J. Neurochem. 55: 10-1812, 1990.
213. LESTIENNE, P., AND G. PONSOT. Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet 1: 885, 1988.
214. LIN, F. H., R. LIN, H. M. WISNIEWSKI, Y. W. HWANG, I. I. GRUNDKE, L. G. HEALY, AND K. IQBAL. Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochem. Biophys. Res. Commun. 182: 238-246, 1992.
215. LINNANE, A. W., A. BAUMER, R. J. MAXWELL, H. PRESTON, C. F. ZHANG, AND S. MARZUKI. Mitochondrial gene mutation: the ageing process and degenerative diseases. Biochem. Int. 22: 1067-1076, 1990.
216. LINNANE, A. W., S. MARZUKI, T. OZAWA, AND M. TANAKA. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1: 642-645, 1989.
217. LINNANE, A. W., C. ZHANG, A. BAUMER, AND P. NAGLEY. Mitochondrial DNA mutation and the ageing process: bioenergy and pharmacological intervention. Mutat. Res. 275: 195-208, 1992.
218. LOMBES, A., J. R. MENDELL, H. NAKASE, R. J. BAROHN, E. BONILLA, M. ZEVIANI, A. J. YATES, J. OMERZA, T. L. GALES, AND K. NAKAHARA. Myoclonic epilepsy and ragged-red fibers with cytochrome oxidase deficiency: neuropathology, biochemistry, and molecular genetics. Ann. Neurol. 26: 20-33, 1989.
219. LOW, R. L., J. M. BUZAN, AND C. L. COUPER. The preference of the mitochondrial endonuclease for a conserved sequence block in mitochondrial DNA is highly conserved during mammalian evolution. Nucleic Acids Res. 16: 6427-6445, 1988.
220. LUFT, R. The development of mitochondrial medicine. Proc. Natl. Acad. Sci. USA 91: 8731-8738, 1994.
221. MANN, V. M., J. M. COOPER, D. KRIGE, S. E. DANIEL, A. H. SCHAPIRA, AND C. D. MARSDEN. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115: 333-342, 1992.
222. MANN, V. M., J. M. COOPER, AND A. H. SCHAPIRA. Quantitation of a mitochondrial DNA deletion in Parkinson's disease. FEBS Lett. 299: 218-222, 1992.
223. MARIOTTI, C., V. TIRANTI, F. CARRARA, B. DALLAPICCOLA, S. DIDONATO, AND M. ZEVIANI. Defective respiratory capacity and mitochondrial protein synthesis in transformant cybrids harboring the tRNALeu(UUR) mutation associated with maternally inherited myopathy and cardiomyopathy. J. Clin. Invest. 93: 1102-1107, 1994.
224. MARTINEZ-RAMON, A., E. KNECHT, V. RUBIO, AND S. GRISOLlA. Levels of carbamoyl phosphate synthetase I in livers of young and old rats assessed by activity and immunoassays and by electron microscopic immunogold procedures. J. Histochem. Cytochem. 38: 371-376, 1990.
225. MASSIE, H. R., AND K. A. KOGUT. Influence of age on mitochondrial enzyme levels in Drosophila. Mech. Ageing Dev. 38: 119-126, 1987.
226. MATSUOKA, T., Y. GOTO, H. HASEGAWA, AND I. NONAKA. Segmental cytochrome c-oxidase deficiency in CPEO: teased muscle fiber analysis. Muscle Nerve 15: 209-213, 1992.
227. 10 in mitochondrial encephalomyopathies. Neuromuscular Disorders 1: 443-447, 1991.
228. MATUMOTO, L., H. KASAMATSU, L. PIKO, AND J. VINOGRAD. Mitochondrial DNA replication in sea urchin oocytes. J. Cell Biol. 63: 146-159, 1974.
229. MCSHANE, M. A., S. R. HAMMANS, M. SWEENEY, I. J. HOLT, T. J. BEATTIE, E. M. BRETT, AND A. E. HARDING. Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am. J. Hum. Genet. 48: 39-42, 1991.
230. MECOCCI, P., U. MACGARVEY, AND M. F. BEAL. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36: 747-751, 1994.
231. MECOCCI, P., U. MACGARVEY, A. E. KAUFMAN, D. KOONTZ, J. M. SHOFFNER, D. C. WALLACE, AND M. F. BEAL. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34: 609-616, 1993.
232. MELMED, C., G. KARPATI, AND S. CARPENTER. Experimental mitochondrial myopathy produced by in vivo uncoupling of oxidative phosphorylation. J. Neurol. Sci. 26: 305-318, 1975.
233. MERANTE, F., I. TEIN, L. BENSON, AND B. H. ROBINSON. Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA(glycine) gene. Am. J. Hum. Genet. 55: 437-446, 1994.
234. MICHAELIS, L. Die vitale Ferbung, eine Darstellungsmethode der Zellgranula. Arch. Mikrosk. Anat. 55: 558-575, 1900.
235. MICHAELIS, L. Fundamentals of oxidation and reduction. In: Currents in Biochemical Research, edtied by D. E. Green. New York: Interscience, 1946, p. 207-227.
236. MILLER, T. R., S. J. GROSSMAN, K. B. SCHECTMAN, D. R. BIELLO, P. A. LUDBROOK, AND A. A. EHSANI. Left ventricular diastolic filling and its association with age. Am. J. Cardiol. 58: 531-535, 1986.
237. MINNICK, D. T., Y. PAVLOV, AND T. A. KUNKEL. The fidelity of the human leading and lagging strand DNA replication apparatus with 8-oxodeoxyguanosine triphosphate. Nucleic Acids Res. 22: 5658-5664, 1994.
238. MIQUEL, J., A. C. ECONOMOS, J. FLEMING, AND J. R. J. JOHNSON. Mitochondrial role in cell aging. Exp. Gerontol. 15: 575-591, 1980.
239. MIQUEL, J., AND J. E. FLEMING. A two-step hypothesis on the mechanisms of in vitro cell aging: cell differentiation followed by intrinsic mitochondrial mutagenesis. Exp. Gerontol. 19: 31-36, 1984.
240. MITA, S., R. RIZZUTO, C. T. MORAES, S. SHANSKE, E. ARNAUDO, G. M. FABRIZI, Y. KOGA, S. DIMAURO, AND E. A. SCHON. Recombination via flanking direct repeats is a major cause of large-scale deletions of human mitochondrial DNA. Nucleic Acids Res. 18: 561-567, 1990.
241. MITA, S., B. SCHMIDT, E. A. SCHON, S. DIMAURO, AND E. BONILLA. Detection of "deleted" mitochondrial genomes in cytochrome-c oxidase-deficient muscle fibers of a patient with Kearns-Sayre syndrome. Proc. Natl. Acad. Sci. USA 86: 9509-9513, 1989.
242. MITCHELL, P. David Keilin's Respiratory Chain Concept and Its Chemiosmotic Consequences. Stockholm: Nobel Found., 1979.
243. MIYABAYASHI, S., H. HANAMIZU, H. ENDO, K. TADA, AND S. HORAI. Mitochondrial DNA deletion in patients with myopathy. In: Mitochondrial Encephalomyapathies. Progress in Neuropathology, edited by T. Sato and S. Mauro. New York: Raven, 1991, vol. 7, p. 153-159.
244. MIZUNO, Y., S. IKEBE, N. HATTORI, T. KONDO, M. TANAKA, AND T. OZAWA. Mitochondrial energy crisis in Parkinson's disease. Adv. Neurol. 60: 282-287, 1993.
245. MIZUNO, Y., S. OHTA, M. TANAKA, S. TAKAMIYA, K. SUZUKI, T. SATO, H. OYA, T. OZAWA, AND Y. KAGAWA. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163: 1450-1455, 1989.
246. +, inhibit mitochondrial NADH-ubiquinone oxidoreductase activity. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 62: 261-263, 1986.
247. MIZUNO, Y., N. SONE, AND T. SAITOH. Inhibition of mitochondrial alpha-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ion. Biochem. Biophys. Res. Commun. 143: 971-976, 1987.
248. +) against mitochondria of mouse brain. J. Neurol. Sci. 86: 97-110, 1988.
249. MIZUNO, Y., K. SUZUKI, AND S. OHTA. Postmortem changes in mitochondrial respiratory enzymes in brain and a preliminary observation in Parkinson's disease. J. Neurol. Sci. 96: 49-57, 1990.
250. MOLLOY, P. L., A. W. LINNANE, AND H. B. LUKINS. Biogenesis of mitochondria: analysis of deletion of mitochondrial antibiotic resistance markers in petite mutants of Saccharomyces cerevisiae. J. Bacteriol. 122: 7-18, 1975.
251. MORAES, C. T., F. ANDREETTA, E. BONILLA, S. SHANSKE, S. DIMAURO, AND E. A. SCHON. Replication-competent human mitochondrial DNA lacking the heavy-strand promoter region. Mol. Cell. Biol. 11: 1631-1637, 1991.
252. MORAES, C. T., S. DIMAURO, M. ZEVIANI, A. LOMBES, S. SHANSKE, A. F. MIRANDA, H. NAKASE, E. BONILLA, L. C. WERNECK, S. SERVIDEI, I. NONAKA, Y. KOGA, A. SPIRO, K. W. BROWNELL, B. SCHMIDT, D. L. SCHOTLAND, M. ZUPANC, D. C. DEVIVO, E. A. SCHON, AND L. P. ROWLAND. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N. Engl. J. Med. 320: 1293-1299, 1989.
253. MORI, K., K. NABAHARA, S. NINOMIYA, Y. GOTO, AND I. NONAKA. Renal and skin involvement in a patient with complete Kearns-Sayre syndrome. Am. J. Med. Genet. 38: 583-587, 1991.
254. MÜLLER-HÖCKER, J. Cytochrome-c-oxidase deficient cardiomyocytes in the human heart - an age-related phenomenon. A histochemical ultracytochemical study. Am. J. Pathol. 134: 1167-1173, 1989.
255. MÜLLER-HÖCKER, J. Cytochrome c oxidase deficient fibres in the limb muscle and diaphragm of man without muscular disease: an age-related alteration. J. Neurol. Sci. 100: 14-21, 1990.
256. MÜLLER-HÖCKER, J., S. STUNKEL, D. PONGRATZ, AND G. HUBNER. Focal deficiency of cytochrome c oxidase and of mitochondrial ATPase with histochemical evidence of loosely coupled oxidative phosphorylation in a mitochondrial myopathy of a patient with bilateral ptosis. An enzyme histochemical, immunocytochemical and fine structural study. J. Neurol. Sci. 69: 27-36, 1985.
257. MÅNSCHER, C., J. MÅLLER-HàCHER, AND B. KADENBACH. Human aging is associated with various point mutations in tRNA genes of mitochondrial DNA. Biol. Chem. Hoppe-Seyler 347: 1099-1104, 1993.
258. MÜNSCHER, C., T. RIEGER, J. MÜLLER-HÖCKER, AND B. KADENBACH. The point mutation of mitochondrial DNA characteristic for MERRF disease is found also in healthy people of different ages. FEBS Lett. 317: 27-30, 1993.
259. NAKAGAWA, H. Y., H. YOSHINO, T. KONDO, Y. MIZUNO, AND S. HORAI. Is Parkinson's disease a mitochondrial disorder? J. Neurol. Sci. 107: 29-33, 1992.
260. NAKAGAWA, Y., H. IKEGAMI, E. YAMATO, K. TAKEKAWA, T. FUJISAWA, Y. HAMADA, H. UEDA, Y. UCHIGATA, T. MIKI, Y. KUMAHARA, AND T. OGIHARA. A new mitochondrial DNA mutation associated with non-insulin-dependent diabetes mellitus. Biochem. Biophys. Res. Commun. 209: 664-668, 1995.
261. NAKASE, H., C. T. MORAES, R. RIZZUTO, A. LOMBES, S. DIMAURO, AND E. A. SCHON. Transcription and translation of deleted mitochondrial genomes in Kearns-Sayre syndrome: implications for pathogenesis. Am. J. Hum. Genet. 46: 418-427, 1990.
262. NASS, S., AND M. M. K. NASS. Intramitochondrial fibers with DNA characteristics. II. Enzymatic and other hydrolytic treatments. J. Cell Biol. 19: 613-629, 1963.
263. NEI, M., AND F. TAJIMA. DNA polymorphism detectable by restriction endonucleases. Genetics 97: 145-163, 1981.
264. NELSON, I., F. DEGOUL, B. OBERMAIER-KUSSER, N. ROMERO, C. BORRONE, C. MARSAC, J. L. VAYSSIERE, K. GERBITZ, M. FARDEAU, AND G. PONSOT. Mapping of heteroplasmic mitochondrial DNA deletions in Kearns-Sayre syndrome. Nucleic Acids Res. 17: 8117-8124, 1989.
265. NELSON, I., M. G. HANNA, N. ALSANJARI, F. SCARAVILLI, J. A. MORGAN-HUGHES, AND A. E. HARDING. A new mitochondrial DNA mutation associated with progressive dementia and chorea: a clinical, pathological, and molecular genetic study. Ann. Neurol. 37: 400-403, 1995.
266. NIKI, Y., S. I. CHIGUSA, AND E. T. MATSUURA. Complete replacement of mitochondrial DNA in Drosophila. Nature Lond. 341: 551-552, 1989.
267. NISHINAKA, Y., S. SUGIYAMA, M. YOKOTA, H. SAITO, AND T. OZAWA. Protective effect of FK506 on ischemia/reperfusion-induced myocardial damage in canine heart. J. Cardiovasc. Pharmacol. 21: 448-454, 1993.
268. NISHIZAWA, M., K. TANAKA, K. SHINOZAWA, T. KUWABARA, T. ATSUMI, T. MIYATAKE, AND E. OHAMA. A mitochondrial encephalomyopathy with cardiomyopathy. A case revealing a defect of complex I in the respiratory chain. J. Neurol. Sci. 78: 189-201, 1987.
269. NOER, A. S., S. MARZUKI, I. TROUNCE, AND E. BYRNE. Mitochondrial DNA deletion in encephalomyopathy. Lancet ii: 1253-1254, 1988.
270. NOER, A. S., H. SUDOYO, P. LERTRIT, D. THYAGARAJAN, P. UTTHANAPHOL, R. KAPSA, E. BYRNE, AND S. MARZUKI. A tRNA-(Lys) mutation in the mtDNA is the causal genetic lesion underlying myoclonic epilepsy and ragged-red fiber (MERRF) syndrome. Am. J. Hum. Genet. 49: 715-722, 1991.
271. NONAKA, I. Mitochondrial diseases. Curr. Opin. Neurol. Neurosurg. 5: 622-632, 1992.
272. OBERMAIER-KUSSER, B., J. MÜLLER-HÖCKER, I. NELSON, P. LESTIENNE, C. ENTER, T. RIEDELE, AND K.-D. GERBITZ. Different copy numbers of apparently identically deleted mitochondrial DNA in tissues from a patient with Kearns-Sayre syndrome detected by PCR. Biochem. Biophys. Res. Commun. 169: 1007-1015, 1990.
273. OBERMAIER-KUSSER, B., I. PAETZKE-BRUNNER, C. ENTER, J. MÜLLER-HÖCKER, S. ZIERZ, W. RUITENBEEK, AND K.-D. GERBITZ. Respiratory chain activity in tissues from patients (MELAS) with a point mutation of the mitochondrial genome [tRNA(Leu-UUR)]. FEBS Lett. 286: 67-70, 1991.
274. 10 in Kearns-Sayre syndrome. Neurology 35: 372-377, 1985.
275. OHAMA, E., S. OHARA, F. IKUTA, K. TANAKA, M. NISHIZAWA, AND T. MIYATAKE. Mitochondrial angiopathy in cerebral vessels of mitochondrial encephalomyopathy. Acta Neuropathol. 74: 226-233, 1987.
276. OHNO, K., M. TANAKA, H. INO, H. SUZUKI, M. TASHIRO, T. IBI, K. SAHASHI, A. TAKAHASHI, AND T. OZAWA. Direct DNA sequencing from colony: analysis of multiple deletions of mitochondrial genome. Biochim Biophys Acta 1090: 9-16, 1991.
277. OHNO, K., M. TANAKA, K. SAHASHI, T. IBI, W. SATO, A. TAKAHASHI, AND T. OZAWA. Mitochondrial DNA deletions in inherited recurrent myoglobinuria. Ann. Neurol. 29, 364-369, 1991.
278. OLTVAI, Z. N., C. L. MILLIMAN, AND S. J. KORSMEYER. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
279. OTA, Y., M. TANAKA, W. SATO, K. OHNO, T. YAMAMOTO, M. MAEHARA, T. NEGORO, K. WATANABE, S. AWAYA, AND T. OZAWA. Detection of platelet mitochondrial DNA deletions in Kearns-Sayre syndrome. Invest. Ophthalmol. Visual Sci. 32: 2667-2675, 1991.
280. OZAWA, T. Mitochondrial cardiomyopathy. Herz 19: 105-118, 1994.
281. OZAWA, T. Mechanism of somatic mitochondrial DNA mutations associated with age and diseases. Biochim. Biophys. Acta 1271: 177-189, 1995.
282. OZAWA, T. Mitochondrial DNA mutations associated with aging and degenerative diseases. Exp. Gerontol. 30: 269-290, 1995.
283. OZAWA, T., K. KATSUMATA, M. HAYAKAWA, T. M., S. SUGIYAMA, T. TANAKA, S. ITOYAMA, S. NUNODA, AND M. SEKIGUCHI. Genotype and phenotype of a severe mitochondrial cardiomyopathy: a recipient of heart transplantation and the genetic control. Biochem. Biophys. Res. Commun. 207: 613-620, 1995.
284. OZAWA, T., K. KATSUMATA, M. HAYAKAWA, M. YONEDA, M. TANAKA, AND S. SUGIYAMA. Mitochondrial DNA mutations and survival rate. Lancet 355: 189, 1995.
285. OZAWA, T., K. SAHASHI, T. NAKASE, AND B. CHANCE. Extensive tissue oxygenation associated with mitochondrial DNA mutations. Biochem. Biophys. Res. Commun. 213: 423-438, 1995.
286. OZAWA, T., M. TANAKA, M. HAYAKAWA, S. SUGIYAMA, W. SATO, K. OHNO, S. IKEBE, AND M. YONEDA. Mitochondrial DNA mutations: types, mechanism and expression. In: Mitochondrial Encephalomyopathies. Progress in Neuropathology, edited by T. Sato and S. DiMauro. New York: Raven, 1991, p. 141-151.
287. OZAWA, T., M. TANAKA, S. IKEBE, K. OHNO, T. KONDO, AND Y. MIZUNO. Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. Biochem. Biophys. Res. Commun. 172: 483-489, 1990.
288. OZAWA, T., M. TANAKA, H. INO, K. OHNO, T. SANO, Y. WADA, M. YONEDA, Y. TANNO, T. MIYATAKE, T. TANAKA, S. ITOYAMA, S. IKEBE, T. KONDO, AND Y. MIZUNO. Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. Biochem. Biophys. Res. Commun. 176: 938-946, 1991.
289. OZAWA, T., M. TANAKA, W. SATO, K. OHNO, M. YONEDA, AND T. YAMAMOTO. Types and mechanism of mitochondrial DNA mutations in mitochondrial myopathy and related diseases. In: Molecular Basis of Neurological Disorders and Their Treatment, edited by J. W. Gorrod, O. Albano, E. Ferrari, and S. Papa. New York: Chapman & Hall, 1991, p. 171-190.
290. OZAWA, T., M. TANAKA, S. SUGIYAMA, K. HATTORI, T. ITO, K. OHNO, A. TAKAHASHI, W. SATO, G. TAKADA, B. MAYUMI, K. YAMAMOTO, K. ADACHI, Y. KOGA, AND H. TOSHIMA. Multiple mitochondrial DNA deletions exist in cardiomyocytes of patients with hypertrophic or dilated cardiomyopathy. Biochem. Biophys. Res. Commun. 170: 830-836, 1990.
291. OZAWA, T., M. TANAKA, S. SUGIYAMA, H. INO, K. OHNO, K. HATTORI, T. OHBAYASHI, T. ITO, H. DEGUCHI, K. KAWAMURA, Y. NAKANE, AND K. HASHIBA. Patients with idiopathic cardiomyopathy belong to the saine mitochondrial DNA gene family of Parkinson's disease and mitochondrial encephalomyopathy. Biochem. Biophys. Res. Commun. 177: 518-525, 1991.
292. OZAWA, T., M. TANAKA, H. SUZUKI, AND M. NISHIKIMI. Structure and function of mitochondria: their organization and disorders. Brain Dev. 9: 76-81, 1987.
293. OZAWA, T., M. YONEDA, M. TANAKA, K. OHNO, W. SATO, H. SUZUKI, M. NISHIKIMI, Y. YAMAMOTO, I. NONAKA, AND S. HORAI. Maternal inheritance of deleted mitochondrial DNA in a family with mitochondrial myopathy. Biochem. Biophys. Res. Commun. 154: 1240-1247, 1988.
294. PARKER, W. D., S. J. BOYSON, A. S. LUDER, AND J. K. PARKS. Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease. Neurology 40: 1231-1234, 1990.
295. PARKER, W. D., S. J. BOYSON, AND J. K. PARKS. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 2G: 719-723, 1989.
296. PARKER, W. D., JR., N. J. MAHR, C. M. FILLEY, J. K. PARKS, D. HUGHES, D. A. YOUNG, AND C. M. CULLUM. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 44: 1086-1090, 1994.
297. PAVLAKIS, S. G., P. C. PHILLIPS, S. DI MAURO, D. C. DE-VIVO, AND L. P. ROWLAND. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann. Neurol. 16: 481-488, 1984.
298. PEIFFER, J., B. KUSTERMANN-KUHN, W. MORTIER, M. POREMBA, W. ROGGENDORF, H. R. SCHOLTE, J. M. SCHRODER, B. WENDTLAND, K. WESSEL, AND C. ZIMMERMANN. Mitochondrial myopathies with necrotizing encephalopathy of the Leigh type. Pathol. Res. Pract. 183: 706-716, 1988.
299. PELLEGRINI, G., G. SCARLATO, AND M. MOGGIO. Ophthalmoplegia plus: neuropathological and metabolic studies with a therapeutic trial in seven cases. Acta Neuropathol. Suppl. 7: 317-319, 1981.
300. PELLEGRINI, G., G. VALLI, P. SERGI, M. MOGGIO, AND G. SCARLATO. Ophthalmoplegia plus. A multisystem disorder of unknown etiopathogenesis. Ital. J. Neurol. Sci. 1: 85-94, 1980.
301. PETERSON, C., AND J. E. GOLDMAN. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc. Natl. Acad. Sci. USA 83: 2758-2762, 1986.
302. PETERSON, C., P. VANDERKLISH, P. SEUBERT, C. COTMAN, AND G. LYNCH. Increased spectrin proteolysis in fibroblasts from aged and Alzheimer donors. Neurosci. Lett. 121: 239-243, 1991.
303. PICCOLI, S. P., P. G. CAIMI, AND M. D. COLE. A conserved sequence at c-myc oncogene chromosomal translocation breakpoints in plasmacytomas. Nature Lond. 310: 327-330, 1984.
304. PIKO, L., AND L. MATSUMOTO. Number of mitochondria and some properties of mitochondrial DNA in the mouse egg. Dev. Biol. 19: 1-10, 1976.
305. PONZETTO, C., N. BRESOLIN, A. BORDONI, M. MOGGIO, G. MEOLA, L. BET, A. PRELLE, AND G. SCARLATO. Kearns-Sayre syndrome: different amounts of deleted mitochondrial DNA are present in several autoptic tissues. J. Neurol. Sci. 96: 207-210, 1990.
306. POULTON, J. Duplications of mitochondrial DNA: implications for pathogenesis. J. Inherited Metab. Dis. 15: 487-498, 1992.
307. POULTON, J., M.E. DEADMAN, L. BINDOFF, K. MORTEN, J. LAND, AND G. BROWN. Families of mtDNA rearrangements can be detected in patients with mtDNA deletions: duplications may be a transient intermediate form. Hum. Mol. Genet. 2: 23-30, 1993.
308. POULTON, J., M. E. DEADMAN, AND R. M. GARDINER. Duplications of mitochondrial DNA in mitochondrial myopathy. Lancet i: 236-240, 1989.
309. POULTON, J., M. E. DEADMAN, AND R. M. GARDINER. Tandem direct duplications of mitochondrial DNA in mitochondrial myopathy: analysis of nucleotide sequence and tissue distribution. Nucleic Acids Res. 17: 10223-10229, 1989.
310. POULTON, J., M. E. DEADMAN, S. RAMACHARAN, AND R. M. GARDINER. Germ-line deletions of mtDNA in mitochondrial myopathy. Am. J. Hum. Genet. 48: 649-653, 1991.
311. POULTON, J., M. E. DEADMAN, M. SOLYMAR, S. RAMCHARAN, AND R. M. GARDINER. Direct tandem duplications of mitochondrial DNA in mitochondrial myopathy. In: Molecular Basis of Neurological Disorders and their Treatment, edited by J. W. Gorrod, O. Albano, E. Ferrari, and S. Papa. New York: Chapman & Hall, 1991, p. 191-199.
312. POULTON, J., M. E. DEADMAN, D. M. TURNBULL, B. LAKE, AND R. M. GARDINER. Detection of mitochondrial DNA deletions in blood using the polymerase chain reaction: non-invasive diagnosis of mitochondrial myopathy. Clin. Genet. 39: 33-38, 1991.
313. PREZANT, R. T., M. SHOHAT, L. JABER, S. PRESSMAN, AND G. N. FISCHEL. Biochemical characterization of a pedigree with mitochondrially inherited deafness. Am. J. Med. Genet. 44: 465-472, 1992.
314. PREZANT, T. R., J. V. AGAPIAN, M. C. BOHLMAN, X. BU, S. OZTAS, W. Q. QIU, K. S. ARNOS, G. A. COROPASSI, JABER, J. I. ROTTER, M. SHOHAT, AND N. FISCHEL-GHODSIAN. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nature Genet. 4: 289-294, 1993.
315. PRIESTLEY, J. Experiments and Observations on Different Kinds of Air (2nd ed.). London: Johnson at St. Paul's Churchyard, 1775.
316. +) analogs and their energized accumulation by mitochondria. Proc. Natl. Acad. Sci. USA 86: 9168-9172, 1989.
317. REICHMANN, H. Enzyme activity analyses along ragged-red and normal single muscle fibres. Histochemistry 98: 131-134, 1992.
318. REID, F. M., G. A. VERNHAM, AND H. T. JACOBS. A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness. Hum. Mutat. 3: 243-247, 1994.
319. RICHTER, C. Do mitochondrial DNA fragments promote cancer and aging? FEBS Lett. 241: 1-5, 1988.
320. RICHTER, C. Reactive oxygen and DNA damage in mitochondria. Mutat. Res. 275: 249-255, 1992.
321. RICHTER, C., J.-W. PARK, AND B. N. AMES. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. USA 85: 6465-6467, 1988.
322. ROBIN, E. D., AND R. WONG. Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells. J. Cell. Physiol. 136: 507-513, 1988.
323. ROTIG, A., M. COLONNA, J. P. BINNEFONT, S. BLANCHE, A. FISHER, J. M. SAUDUBRAY, AND A. MUNNICH. Mitochondrial DNA deletion in Peason's marrow/pancreas syndrome. Lancet i: 902-903, 1989.
324. ROTIG, A., V. CORMIER, S. BLANCHE, J. P. BONNEFONT, F. LEDEIST, N. ROMERO, J. SCHMITZ, P. RUSTIN, A. FISCHER, AND J. M. SAUDUBRAY. Pearson's marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J. Clin. Invest. 86: 1601-1608, 1990.
325. ROTIG, A., V. CORMIER, F. KOLL, C. E. MIZE, J. M. SAUDUBRAY, A. VEERMAN, H. A. PEARSON, AND A. MUNNICH. Site-specific deletions of the mitochondrial genome in the Pearson marrow-pancreas syndrome. Genomics 10: 502-504, 1991.
326. ROWLAND, L. P., D.M. BLAKE, M. HIRANO, M.S. DI, E. A. SCHON, A. P. HAYS, AND D. C. DEVIVO. Clinical syndromes associated with ragged red fibers. Rev. Neurol. Paris 147: 467-473, 1991.
327. SAHASHI, K., K. OHNO, M. TANAKA, T. IBI, T. YAMAMOTO, M. TASHIRO, W. SATO, A. TAKAHASHI, AND T. OZAWA. Cytoplasmic body and mitochondrial DNA deletion. J. Neurol. Sci. 99: 291-300, 1990.
328. SAHASHI, K., M. TANAKA, M. TASHIRO, K. OHNO, I. IBI, A. TAKAHASHI, AND T. OZAWA. Increased mitochondrial DNA deletions in the skeletal muscle of myotonic dystrophy. Gerontology 38: 18-29, 1992.
329. SAIKI, R. K., D. H. GELFAND, S. STOFFEL, S. J. SCHARF, R. HIGUCHI, G. T. HORN, K. B. MULLIS, AND H. A. ERLICH. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science Wash. DC 239: 487-494, 1988.
330. SANO, T., K. BAN, T. ICHIKI, M. KOBAYASHI, M. TANAKA, K. OHNO, AND T. OZAWA. Molecular and genetic analyses of two patients with Pearson's marrow-pancreas syndrome. Pediatr. Res. 34: 105-110, 1993.
331. SARAIVA, A. A., M. M. BORGES, M. D. MADEIRA, M. A. TAVARES, AND B. M. PAULA. Mitochondrial abnormalities in cortical dendrites from patients with Alzheimer's disease. J. Submicrosc. Cytol. 17: 459-464, 1985.
332. SATO, W., K. HAYASAKA, K. KOMATSU, Y. SAWAISHI, K. SAKEMI, Y. SHOJI, AND
333. SATO, W., M. TANAKA, K. OHNO, T. YAMAMOTO, G. TAKADA, AND T. OZAWA. Multiple populations of deleted mitochondrial DNA detected by a novel gene amplification method. Biochem. Biophys. Res. Commun. 162: 664-672, 1989.
334. SATO, W., M. TANAKA, S. SUGIYAMA, T. NEMOTO, K. HARADA, Y. MIURA, Y. KOBAYASHI, A. GOTO, G. TAKADA, AND T. OZAWA. Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Am. Heart J. 128: 733-741, 1994.
335. SATOH, M., AND T. KUROIWA. Organization of multiple nucleoids and DNA molecules in mitochondria of a human cell. Exp. Cell Res. 196: 137-140, 1991.
336. SCELSI, R., C. MARCHETTI, R. ROSSO, AND M. SCELSI. Mitochondrial abnormalities in some human muscular diseases and in experimental ischemic myopathy. Biochem. Exp. Biol. 13: 199-195, 1977.
337. SCHAPIRA, A. H., V. M. MANN, J. M. COOPER, D. DEXTER, S. E. DANIEL, P. JENNER, J. B. CLARK, AND C. D. MARSDEN. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55: 2142-2145, 1990.
338. SCHAPIRA, A. H., V. M. MANN, J. M. COOPER, D. KRIGE, P. J. JENNER, AND C. D. MARSDEN. Mitochondrial function in Parkinson's disease. Ann. Neurol. 32: S116-S124, 1992.
339. SCHAPIRA, A. H. V., J. M. COOPER, D. DEXTER, J. B. CLARK, P. JENNER, AND C. D. MARSDEN. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54: 823-827, 1990.
340. SCHAPIRA, A. H. V., J. M. COOPER, D. DEXTER, P. JENNER, J. B. CLARK, AND C. D. MARSDEN. Mitochondrial complex I deficiency in Parkinson's disease. Lancet i: 1269, 1989.
341. SCHENDEL, S. A., R. M. PEARL, AND S. J. DE'ARMOND. Pathophysiology of cleft lip muscle. Plast. Reconstr. Surg. 83: 777-784, 1989.
342. SCHOLTE, H. R., H. F. M. BUSCH, H. D. BAKKER, J. M. BOGAARD, I. E. M. LUYT-HOUWEN, AND L. P. KUYTE. Riboflavin-responsive complex I deficiency. Biochim. Biophys. Acta 1271: 75-83, 1995.
343. SCHON, E. A., R. RIZZUTO, C. T. MORAES, H. NAKASE, M. ZEVIANI, AND S. DIMAURO. A direct repeat is a hot spot for large-scale deletion of human mitochondrial DNA. Science Wash. DC 244: 346-349, 1989.
344. SEIBEL, P., F. DEGOUL, G. BONNE, N. ROMERO, D. FRANCOIS, J. M. PATURNEAU, F. ZIEGLER, B. EYMARD, M. FARDEAU, AND C. MARSAC. Genetic biochemical and pathophysiological characterization of a familial mitochondrial encephalomyopathy (MERRF). J. Neurol. Sci. 105: 217-224, 1991.
345. SEIBEL, P., F. DEGOUL, N. ROMERO, C. MARSAC, AND B. KADENBACH. Identification of point mutations by mispairing PCR as exemplified in MERRF disease. Biochem. Biophys. Res. Commun. 173: 561-565, 1990.
346. SERVIDEI, S., M. ZEVIANI, G. MANFREDI, E. RICCI, G. SILVESTRI, E. BERTINI, C. GELLERA, S. DIMAURO, S. DIDONATO, AND P. TONALI. Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical, morphologic, and biochemical studies. Neurology 41: 1053-1059, 1991.
347. SHANSKE, S., C. T. MORAES, A. LOMBES, A. F. MIRANDA, E. BONILLA, P. LEWIS, M. A. WHELAN, C. A. ELLSWORTH, AND S. DIMAURO. Widespread tissue distribution of mitochondrial DNA deletions in Kearns-Sayre syndrome. Neurology 40: 24-28, 1990.
348. SHAPIRA, Y., S. D. CEDERBAUM, P. A. CANCILLA, D. NIELSEN, AND B. M. LIPPE. Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia. Neurology 25: 614-621, 1975.
349. SHARMA, R., AND S. K. PATNAIK. Regulation of aspartate amino-transferase isoenzymes by hydrocortisone in the liver of aging rats. Arch. Gerontol. Geriatr. 6: 27-32, 1987.
350. SHATZ, G., E. HASLBRUNNER, AND H. TUPPY. Deoxyribonucleic acid associated with yeast mitochondria. Biochem. Biophys. Res. Commun. 15: 127-132, 1964.
351. SHAY, J. W., T. BABA, Q. M. ZHAN, N. KAMIMURA, AND J. A. CUTHBERT. HeLaTG cells have mitochondrial DNA inserted into the c-myc oncogene. Oncogene 6: 1869-1874, 1991.
352. SHAY, J. W., AND H. WERBIN. New evidence for the insertion of mitochondrial DNA into the human genome: significance for cancer and aging. Mutat. Res. 275: 227-235, 1992.
353. SHMOOKLER-REIS, R. J., AND S. GOLDSTEIN. Mitochondrial DNA in mortal and immortal human cells. Genome number, integrity, and methylation. J. Biol. Chem. 258: 9078-9085, 1983.
354. SHOFFNER, J. M., M. G. BIALER, S. G. PAVLAKIS, M. T. LOTT, A. KAUFMAN, J. DIXON, S. TEICHBERG, AND D. C. WALLACE. Mitochondrial encephalomyopathy associated with a single nucleotide pair deletion in the mitochondrial tRNALeu(UUR) gene. Neurology 45: 286-292, 1995.
355. SHOFFNER, J. M., M. D. BROWN, A. TORRONI, M. T. LOTT, M. R. CABELL, S. S. MIRRA, M. F. BEAL, C. YANG, M. GEARING, R. SALVO, R. L. WATTS, J. L. JUNCOS, L. A. HANSEN, B. J. CRAIN, M. FAYAD, C. L. RECKORD, AND D. C. WALLACE. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17: 171-184, 1993.
356. SHOFFNER, J. M., M. T. LOTT, A. M. S. LEZZA, P. SEIBEL, S. W. BALLINGER, AND D. C. WALLACE. Myoclonic epilepsy and ragged red fibers disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 61: 931-937, 1990.
357. SHOFFNER, J. M., M. T. LOTT, A. S. VOLJAVEC, S. A. SOUEIDAN, D. A. COSTIGAN, AND D. C. WALLACE. Spontaneous Kearns-Sayre/ chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proc. Natl. Acad. Sci. USA 86: 7952-7956, 1989.
358. SHOFFNER, J. M., M. T. LOTT, AND D. C. WALLACE. MERRF: a model disease for understanding the principles of mitochondrial genetics. Rev. Neurol. Paris 147: 431-435, 1991.
359. SHOFFNER, J. M., R. L. WATTS, J. L. JUNCOS, A. TORRONI, AND D. C. WALLACE. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann. Neurol. 30: 332-339, 1991.
360. SHOUBRIDGE, E. A., G. KARPATI, AND K. E. HASTINGS. Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease. Cell 62: 43-49, 1990.
361. SIMONETTI, S., X. CHEN, S. DIMAURO, AND E. A. SCHON. Accumulation of deletions in human mitochondrial DNA during normal aging: analysis by quantitative PCR. Biochim. Biophys. Acta 1180: 113-122, 1992.
362. SIMS, N. R., J. M. FINEGAN, J. P. BLASS, D. M. BOWEN, AND D. NEARY. Mitochondrial function in brain tissue in primary degenerative dementia. Brain. Res. 436: 30-38, 1987.
363. SINGER, T. P., AND R. R. RAMSAY. The reaction sites of rotenone and ubiquinone with mitochondrial NADH dehydrogenase. Biochim. Biophys. Acta 1187: 198-202, 1994.
364. SLATER, E. C. Application of inhibitors and uncouplers for a study of oxidative phosphorylation. In: Methods in Enzymology, edited by R. W. Estabrook and M. E. Pullman. New York: Academic, 1966, vol. 10, p. 48-57.
365. SOHAL, R. S., L. A. ARNOLD, AND B. H. SOHAL. Age-related changes in antioxidant enzymes and prooxidant generation in tissues of the rat with special reference to parameters in two insect species. Free Radical Biol. Med. 9: 495-500, 1990.
366. SOLMI, R., F. PALLOTTI, M. RUGOLO, M. L. GENOVA, E. ESTORNELL, P. GHETTI, A. PUGNALONI, G. BIAGINI, C. RIZZOLI, AND G. LENAZ. Lack of major mitochondrial bioenergetic changes in cultured skin fibroblasts from aged individuals. Biochem. Mol. Biol. Int. 33: 477-484, 1994.
367. SOONG, N. W., D. R. HINTON, G. CORTOPASSI, AND N. ARNHEIM. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nature Genet. 2: 318-323, 1992.
368. STADHOUDERS, A. M., AND R. C. SENGERS. Morphological observations in skeletal muscle from patients with a mitochondrial myopathy. J. Inherited Metab. Dis. 10, Suppl: S62-S80, 1987.
369. SUGIYAMA, S., K. HATTORI, M. HAYAKAWA, AND T. OZAWA. Quantitative analysis of age-associated accumulation of mitochondrial DNA with deletion in human hearts. Biochem. Biophys. Res. Commun. 180: 894-899, 1991.
370. SUGIYAMA, S., M. TAKASAWA, M. HAYAKAWA, AND T. OZAWA. Changes in skeletal muscle, heart and liver mitochondrial electron transport activities in rats and dogs of various ages. Biochem. Mol. Biol. Int. 30: 937-944, 1993.
371. SUOMALAINEN, A., J. KAUKONEN, P. AMATI, R. TIMONEN, M. HALTIA, J. WEISSENBACH, M. ZEVIANI, H. SOMER, AND L. PELTONEN. An autosomal locus predisposing to deletions of mitochondrial DNA. Nature Genet. 9: 146-151, 1995.
372. SUOMALAINEN, A., A. PAETAU, H. LEINONEN, A. MAJANDER, L. PELTONEN, AND H. SOMER. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 340: 1319-1320, 1992.
373. SUZUKI, H., Y. HOSOKAWA, M. NISHIKIMI, AND T. OZAWA. Existence of common homologous elements in the transcriptional regulatory regions of human nuclear genes and mitochondrial gene for the oxidative phosphorylation system. J. Biol. Chem 266: 2333-2338, 1991.
374. SUZUKI, K., Y. MIZUNO, AND M. YOSHIDA. Inhibition of mitochondrial NADH-ubiquinone oxidoreductase activity and ATP synthesis by tetrahydroisoquinoline. Neurosci. Lett. 86: 105-108, 1988.
375. TAKASAWA, M., M. HAYAKAWA, S. SUGIYAMA, K. HATTORI, T. ITO, AND T. OZAWA. Age-associated damage in mitochondrial function in rat heart. Exp. Gerontol. 28: 269-280, 1993.
376. TANAKA, M., H. INO, K. OHNO, K. HATTORI, W. SATO, AND T. OZAWA. Mitochondrial tRNAIle mutation in fatal infantile cardiomyopathy. Lancet 336: 1452, 1990.
377. TANAKA, M., H. INO, K. OHNO, T. OHBAYASHI, S. IKEBE, T. SANO, T. ICHIKI, M. KOBAYASHI, Y. WADA, AND T. OZAWA. Mitochondrial DNA tRNALeu (UUR) mutation in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Biochem. Biophys. Res. Commun. 174: 861-868, 1991.
378. TANAKA, M., S. MIYABAYASHI, M. NISHIKIMI, H. SUZUKI, S. Y., K. ITO, K. NARISAWA, K. TADA, AND T. OZAWA. Extensive defects of mitochondrial electron-transfer chain in muscular cytochrome c oxidase deficiency. Pediatr. Res. 24: 447-453, 1988.
379. TANAKA, M., M. NISHIKIMI, AND T. OZAWA. Lack of subunit II of cytochrome c oxidase in a patient with mitochondrial myopathy. Ann. NY Acad. Sci. 488: 503-504, 1987.
380. TANAKA, M., M. NISHIKIMI, H. SUZUKI, T. OZAWA, T. ICHIKI, M. KOBAYASHI, AND Y. WADA. Variation in the levels of complex I subunits among tissues in a patient with mitochondrial encephalomyopathy and renal dysfunction. Biochem. Int. 14: 735-739, 1987.
381. TANAKA, M., M. NISHIKIMI, H. SUZUKI, T. OZAWA, M. NISHIZAWA, K. TANAKA, AND T. MIYATAKE. Deficiency of subunits in heart mitochondrial NADH-ubiquinone oxidoreductase of a patient with mitochondrial encephalomyopathy and cardiomyopathy. Biochem. Biophys. Res. Commun. 140: 88-93, 1986.
382. TANAKA, M., M. NISHIKIMI, H. SUZUKI, T. OZAWA, E. OKINO, AND H. TAKAHASHI. Multiple cytochrome deficiency and deteriorated mitochondrial polypeptide composition in fatal infantile mitochondrial myopathy and renal dysfunction. Biochem. Biophys. Res. Commun. 137: 911-916, 1986.
383. TANAKA, M., W. SATO, W. SATO, K. OHNO, T. YAMAMOTO, AND T. OZAWA. Direct sequencing of deleted mitochondrial DNA in myopathic patients. Biochem. Biophys. Res. Commun. 164: 156-163, 1989.
384. TANIIKE, M., H. FUKUSHIMA, I. YANAGIHARA, H. TSUKAMOTO, J. TANAKA, H. FUJIMURA, T. NAGAI, T. SANO, K. YAMAOKA, AND K. INUI. Mitochondrial tRNA(Ile) mutation in fatal cardiomyopathy. Biochem. Biophys. Res. Commun. 186: 47-53, 1992.
385. TANNO, Y., M. YONEDA, I. NONAKA, K. TANAKA, T. MIYATAKE, AND S. TSUJI. Quantitation of mitochondrial DNA carrying tRNALys mutation in MERRF patients. Biochem. Biophys. Res. Commun. 179: 880-885, 1991.
386. TAUCHI, H., AND T. SATO. Age changes in size and numbers of mitochondria of human hepatic cells. J. Gerontol. 23: 454-461, 1968.
387. 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease. J. Neurol. Sci. 125: 77-81, 1994.
388. THORSNESS, P. E., AND T. D. FOX. Escape of DNA from mitochondria to the nucleus in Saccaromyces cerevisiae. Nature Lond. 346: 376-379, 1990.
389. TIPTON, K. F., AND T. P. SINGER. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61: 1191-1206, 1993.
390. TIRANTI, V., P. CHARIOT, F. CARELLA, A. TOSCANO, P. SOLIVERI, P. GIRLANDA, F. CARRARA, G. M. FRATTA, F. M. REID, C. MARIOTTI, AND M. ZEVIANI. Maternally inherited hearing loss, ataxia and myoclonus associated with a novel point mutation in mitochondrial tRNASer(UCN) gene. Hum. Mol. Genet. 4: 1421-1427, 1995.
391. TORII, K., S. SUGIYAMA, K. TAKAGI, T. SATAKE, AND T. OZAWA. Age-related decrease in respiratory muscle mitochondrial function in rats. Am. J. Respir. Cell. Mol. Biol. 6: 88-92, 1992.
392. TORII, K., S. SUGIYAMA, M. TANAKA, K. TAKAGI, Y. HANAKI, K. IIDA, M. MATSUYAMA, N. HIRABAYASHI, Y. UNO, AND T. OZAWA. Aging-associated deletions of human diaphragmatic mitochondrial DNA. Am. J. Respir. Cell. Mol. Biol. 6: 543-549, 1992.
393. TROUNCE, I., E. BYRNE, AND S. MARZUKI. Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing. Lancet i: 637-639, 1989.
394. TROUNCE, I., E. BYRNE, S. MARZUKI, X. DENNETT, H. SUDOYO, F. MASTAGLIA, AND S. F. BERKOVIC. Functional respiratory chain studies in subjects with chronic progressive external ophthalmoplegia and large heteroplasmic mitochondrial DNA deletions. J. Neurol. Sci. 102: 92-99, 1991.
395. TSUJIMOTO, Y., AND C. M. CROCE. Analysis of the structure, transcripts, and protein products of bc1-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 83: 5214-5218, 1986.
396. TULINIUS, M. H., E. HOLME, B. KRISTIANSSON, N. G. LARSSON, AND A. OLDFORS. Mitochondrial encephalomyopathies in childhood. II. Clinical manifestations and syndromes. J. Pediatr. 119: 251-259, 1991.
397. TURNBULL, D. M., M. A. JOHNSON, D. J. DICK, N. E. CARTLIDGE, AND H. S. SHERRATT. Partial cytochrome oxidase deficiency without subsarcolemmal accumulation of mitochondria in chronic progressive external ophthalmoplegia. J. Neurol. Sci. 70: 93-100, 1985.
398. TZAGOLOFF, A. Mitochondrial biogenesis. In: Mitochondria. New York: Plenum, 1982, p. 235-266.
399. TZAGOLOFF, A. Mitochondrial genetics. In: Mitochondria. New York: Plenum, 1982, p.267-322.
400. VAN DEN OUWELAND, J. M. W., H. H. P. J. LEMKES, W. RUITENBEEK, L. A. SANDKUIJL, M. F. DE VIJLDER, P. A. A. STRUYVENBERG, J. J. P. VAN DE KAMP, AND J. A. MAASSEN. Mutation in mitochondrial tRNAleu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genet. 1: 368-371, 1992.
401. VILKKI, J., M. L. SAVONTAUS, AND E. K. NIKOSKELAINEN. Segregation of mitochondrial genomes in a heteroplasmic lineage with Leber hereditary optic neuroretinopathy. Am. J. Hum. Genet. 47: 95-100, 1990.
402. WALLACE, D. C. Diseases of the mitochondrial DNA. Annu. Rev. Biochem. 61: 1175-1212, 1992.
403. WALLACE, D. C. Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science Wash. DC 256: 628-632, 1992.
404. WALLACE, D. C., G. SINGH, M. T. LOTT, J. A. HODGE, T. G. SCHURR, A. M. S. LEZZA, L. J. EISAS, AND E. K. NIKOSKELAINEN. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science Wash. DC 242: 1427-1430, 1988.
405. WALLACE, D. C., J. H. YE, S. N. NECKELMANN, G. SINGH, K. A. WEBSTER, AND B. D. GREENBERG. Sequence analysis of cDNAs for the human and bovine ATP synthase β-subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr. Genet. 12: 81-90, 1987.
406. WALLACE, D. C., X. ZHENG, M. T. LOTT, J. M. SHOFFNER, J. A. HODGE, R. I. KELLEY, C. M. EPSTEIN, AND L. C. HOPKINS. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 66: 601-610, 1988.
407. WARBURG, O. Über Eisen, den sauerstoffübertragenden Bestandteil des Atmungsferments. Biochem. Z. 152: 479-494, 1924.
408. WARBURG, O., AND E. NEGELEIN. Über das Absorptionsspektrum des Atmungsferments. Biochem. Z. 214: 64-100, 1929.
409. WATSON, J. D., N. H. HOPKINS, J. W. ROBERTS, J. A. STEITZ, AND J. A. WEINER. Molecular Biology of the Gene (4th ed.). Menlo Park, CA: Benjamin/Cummings, 1987.
410. WESSEL, K., M. POREMBA, J. PFEIFFER, AND W. ROGGENDORF. Mitochondrial encephalomyopathy: clinical aspects, CT morphology and neuropathology. Fortschr. Neurol. Psychiatr. 56: 154-162, 1988.
411. WHITE, F. A., AND C. L. BUNN. Segregation of mitochondrial DNA in human somatic cell hybrids. Mol. Gen. Genet. 197: 453-460, 1984.
412. WHITE, F. A., AND C. L. BUNN. Restriction enzyme analysis of mitochondrial DNA in aging human cells. Mech. Ageing Dev. 30: 153-168, 1985.
413. WHITTAM, T. S., A. G. CLARK, M. STONEKING, R. L. CANN, AND A. C. WILSON. Allelic variation in human mitochondrial genes based on patterns of restriction site polymorphism. Proc. Natl. Acad. Sci. USA 83: 9611-9615, 1986.
414. WIELAND, H. Über den Mechanismus der Oxydationsvorgènge. Ergebn. Physiol. 20: 477-518, 1922.
415. WIESNER, R. J., J. C. RUEGG, AND I. MORANO. Counting target molecules by exponential polymerase chain reaction: copy number of mitochondrial DNA in rat tissues. Biochem. Biophys. Res. Commun. 183: 553-559, 1992.
416. WILLIAMS, R. S. Mitochondrial gene expression in mammalian striated muscle. Evidence that variation in gene dosage is the major regulatory event. J. Biol. Chem. 261: 12390-12394, 1986.
417. WILLIAMS, R. S., S. SALMONS, E. A. NEWSHOLME, R. E. KAUFMAN, AND J. MELLOR. Regulation of nuclear and mitochondrial gene expression by contractile activity in skeletal muscle. J. Biol. Chem. 261: 376-380, 1986.
418. WILLUMSEN, N. J., L. VESTERGAARD, AND E. H. LARSEN. Uneven distribution of mitochondrial DNA mutation in MERRF dizygotic twins. J. Neurol. Sci. 110: 144-148, 1992.
419. WONG, T. W., AND D. A. CLAYTON. In vitro replication of human mitochondrial DNA: accurate initiation at the origin of light-strand synthesis. Cell 42: 951-958, 1985.
420. WYLLIE, A. H. Death gets a brake. Nature Lond. 369: 272-273, 1994.
421. YAMAMOTO, H., M. TANAKA, M. KATAYAMA, T. OBAYASHI, Y. NIMURA, AND T. OZAWA. Significant existence of deleted mitochondrial DNA in cirrhotic liver surrounding hepatic tumor. Biochem. Biophys. Res. Commun. 182: 913-920, 1992.
422. 10 administration. J. Neurol. Neurosurg. Psychiatry 50: 1475-1481, 1987.
423. YEN, T. C., Y. S. CHEN, K. L. KING, S. H. YEH, AND Y. H. WEI. Liver mitochondrial respiratory functions decline with age. Biochem. Biophys. Res. Commun. 165: 944-1003, 1989.
424. YEN, T. C., J. H. SU, K. L. KING, AND Y. H. WEI. Ageing-associated 5 kb deletion in human liver mitochondrial DNA. Biochem. Biophys. Res. Commun. 178: 124-131, 1991.
425. YONEDA, M., A. CHOMYN, A. MARTINUZZI, O. HURKO, AND G. ATTARDI. Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy. Proc. Natl. Acad. Sci. USA 89: 11164-11168, 1992.
426. YONEDA, M., K. KATSUMATA, M. HAYAKAWA, M. TANAKA, AND T. OZAWA. Oxygen stress induces an apoptotic cell death associated with fragmentation of mitochondrial genome. Biochem. Biophys. Res. Commun. 209: 723-729, 1995.
427. YONEDA, M., T. MIYATAKE, AND G. ATTARDI. Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles. Mol. Cell. Biol. 14: 2699-2712, 1994.
428. YONEDA, M., M. TANAKA, M. NISHIKIMI, H. SUZUKI, K. TANAKA, M. NISHIZAWA, T. ATSUMI, E. OHAMA, S. HORAI, F. IKUTA, T. MIYATAKE, AND T. OZAWA. Pleiotropic molecular defects in energy-transducing complexes in mitochondrial encephalomyopathy (MELAS). J. Neurol. Sci. 92: 143-158, 1989.
429. YONEDA, M., S. TANNO, S. HORAI, T. OZAWA, T. MIYATAKE, AND S. TSUJI. A common mitochondrial DNA mutation in the t-RNALys of patients with myoclonus epilepsy associated with ragged-red fibers. Biochem. Int. 27: 789-796, 1990.
430. YONEDA, M., S. TSUJI, T. YAMAUCHI, T. INUZUKA, T. MIYATAKE, S. HORAI, AND T. OZAWA. Mitochondrial DNA mutation in a Japanese family with Leber's hereditary optic neuropathy. Lancet i: 1076-1077, 1989.
431. YOSHINO, H., Y. NAKAGAWA-HATTORI, T. KONDO, AND Y. MIZUNO. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease. J. Neural Transm. Parkinson's Dis. Dementia Sect. 4: 27-34, 1992.
432. YU, B. P. Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74: 139-162, 1994.
433. YUZAKI, M., N. OHKOSHI, I. KANAZAWA, Y. KAGAWA, AND S. OHTA. Multiple deletions in mitochondrial DNA at direct repeats of non-D-loop regions in cases of familial mitochondrial myopathy. Biochem. Biophys. Res. Commun. 164: 1352-1357, 1989.
434. ZEVIANI, M., P. AMATI, N. BRESOLIN, C. ANTOZZI, G. PICCOLO, A. TOSCANO, AND S. DIDONATO. Rapid detection of the A - G(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF). Am. J. Hum. Genet. 48: 203-211, 1991.
435. ZEVIANI, M., C. GELLERA, C. ANTOZZI, M. RIMOLDI, L. MORANDI, F. VILLANI, V. TIRANTI, AND S. DIDONATO. Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR). Lancet 338: 143-147, 1991.
436. ZEVIANI, M., C. GELLERA, M. PANNACCI, G. UZIEL, A. PRELLE, S. SERVIDEI, AND S. DIDONATO. Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies. Ann. Neurol. 28: 94-97, 1990.
437. ZEVIANI, M., C. T. MORAES, S. DIMAURO, H. NAKASE, E. BONILLA, E. SCHON, AND L. P. RAWLAND. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 38: 1339-1346, 1988.
438. ZEVIANI, M., S. SERVIDEI, C. GELLERA, E. BERTINI, S. DIMAURO, AND S. DIDONATO. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature Lond. 339: 309-311, 1989.
439. ZHANG, C., A. BAUMER, R. J. MAXWELL, A. W. LINNANE, AND P. NAGLEY. Multiple mitochondrial DNA deletions in an elderly human individual. FEBS Lett. 297: 34-38, 1992.
440. ZHANG, C., A. LINNANE, AND P. NAGLEY. Occurrence of a particular base substitution (3243 A to G) in mitochondrial DNA of tissues of ageing humans. Biochem. Biophys. Res. Commun. 195: 1104-1110, 1993.